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Abstract
Congruent, low-friction relative movement between the articulating elements of a synovial joint is an essential pre-requisite 
for sustained, eicient, function. Where disorders of joint formation or maintenance exist, mechanical overloading and osteo-
arthritis (OA) follow. The heritable component of OA accounts for ~ 50% of susceptible risk. Although almost 100 genetic 
risk loci for OA have now been identiied, and the epidemiological relationship between joint development, joint shape and 
osteoarthritis is well established, we still have only a limited understanding of the contribution that genetic variation makes 
to joint shape and how this modulates OA risk. In this article, a brief overview of synovial joint development and its genetic 
regulation is followed by a review of current knowledge on the genetic epidemiology of established joint shape disorders and 
common shape variation. A summary of current genetic epidemiology of OA is also given, together with current evidence 
on the genetic overlap between shape variation and OA. Finally, the established genetic risk loci for both joint shape and 
osteoarthritis are discussed.
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Introduction
Osteoarthritis (OA) is a disorder involving movable joints 
characterized by cell stress and extracellular matrix damage 
leading to cartilage degradation, bone remodelling, osteo-
phyte formation, joint inlammation and loss of normal joint 
function that manifests clinically with pain, deformity, and 
disability https ://www.oarsi .org/educa tion/oarsi -resou rces/
oarsi -white -paper -oa-serio us-disea se. Approximately, 240 
million people (3.3% of the world’s population) live with OA 
[1]. Between 1990 and 2013 osteoarthritis was responsible 
for a 75% increase in years living with disability to 13 mil-
lion [2], behind only diabetes (135%) and dementia (84%) in 
increasing prevalence. This reduced physical activity results 
in an increased all-cause mortality for OA suferers versus 
the general population (standardised mortality ratio 1.55, 
95% conidence interval 1.41–1.70) [3], largely attributable 
to an excess cardiovascular risk. In 2003, OA accounted for 
1.2% of United States domestic product ($128billion, direct 
costs $80Billion and loss of earnings $47Billion) [4]. By 
2013, this igure had increased to $304Billion [5].
The epidemiological risk factors for OA are well-estab-
lished and include older age, female sex, obesity, joint 
injury, bone morphology and family history. The heritability 
of OA has been estimated in studies of monozygotic versus 
dizygotic twins to range between 40% (knee) and 60% (hip) 
[6, 7], and follows a non-Mendelian pattern consistent with 
the common, complex nature of the disease. The interaction 
between environmental and heritable risk factors for OA also 
difers with age, between men and women, and with body 
mass index [8]. In recent years it has become more widely 
appreciated that underlying joint shape is a strong risk factor 
for OA. This realisation has led to an explosion in the use 
of surgical interventions designed to restore the joint to a 
more anatomically normal shape and improve mechanical 
symptoms [9–11]. Only time will establish whether such 
interventions alter the natural history of OA. In this article, 
we provide a brief overview of the morphology and devel-
opment of synovial joints, review the genetic epidemiology 
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of joint shape as it relates to OA genetic epidemiology, and 
consider to what extent this heritable component is shared.
What is a Synovial Joint?
Synovial joints, characterised by a luid-illed synovial 
space between the bones, are the most lexible type of joint 
in the body, allowing movement between the bone ends in 
up to 6 degrees of freedom and across an arc of movement 
of up to 140 degrees. Synovial joints are the most common 
type of joint, and allow great facility in both the range and 
type of movement from repetitive, weight-bearing activity 
through to intricate, ine motor functions. Such freedom 
of movement and resilience requires exquisite design. All 
synovial joints comprise subchondral bone that is lined by 
hyaline cartilage and enclosed by a strong ibrous capsule 
that is lined by synovial tissue. The outer ibrous capsule 
is reinforced by ligaments that act as primary stabilisers of 
the joint. The joint cavity is illed with lubricating synovial 
luid that is synthesised by the synovial membrane and 
hyaline cartilage, allowing low-friction motion between 
the joint elements. The joint cavity may also contain ibro-
cartilage extensions of the capsule that function to spread 
load more evenly within the joint and act as a secondary 
stabiliser (knee menisci and hip labrum). Further stabilisa-
tion of the joint is provided by accessory ligaments that 
may be separate to, or fused with, the capsule.
Synovial joints perform a variety of movements, neces-
sitating variation on the same basic design. These include 
pivot joints that allow rotation (upper cervical vertebra), 
hinge joints that allow movement in only 1 plane but can 
allow transfer of large forces to create great power (knee, 
elbow), saddle joints that allow fine multidirectional 
movement (small joints of the hand), plane joints that 
allow limited sliding motion whilst resisting large forces 
(midfoot), condyloid joints that allow complex composite 
movement (wrist), and ball and socket joints that can rotate 
and lex almost freely in any direction whilst maintaining 
great stability (shoulder, hip).
An Overview of Synovial Joint Development
Despite the heterogeneity of synovial joint morphology, 
common signalling pathways underpin their development. 
In this section, we give a brief overview of the process, 
although dedicated reviews of this topic can be found else-
where [12, 13]. Bones and joints develop in mesoderm, 
comprising mesenchymal cells that have the ability to 
diferentiate into ibroblasts, chondroblasts or osteoblasts 
and the blood vessels and connective tissues of the limb. 
Synovial joint formation begins at approximately week 
7 of embryogenesis as interzonal mesenchyme between 
the developing bones [14]. Figure 1 shows joint develop-
ment from mouse data, but the same stages are followed 
in humans. The outer layers of the interzone form the 
long bone epiphyses through endochondral ossiication 
[15], whilst the inner layer diferentiates into the articular 
surfaces. Removal of the interzonal mesenchyme during 
embryonic development results in fusion of the adjacent 
developing bones [16].
At the molecular level, the appearance of the interzone 
is accompanied by a decrease in type II collagen expres-
sion [17], and an increase in growth diferentiating factor 5 
(GDF5) and bone morphogenetic protein 2 (BMP2) expres-
sion. GDF5, a member of the transforming growth factor 
beta superfamily [18], is a key early marker of interzone 
development and segmentation of skeletal elements [19, 20]. 
Gdf5 knockout results in failure of synovial joint develop-
ment in mice [20]. Whilst GDF5 is an essential requirement 
for joint development, it is not speciic to synovial joints, and 
its over-expression also results in failure of joint formation, 
increase in size of the skeletal elements and over-prolifera-
tion of epiphyseal cartilage [21].
Interzone expression gradients of BMPs and their inhibi-
tors Noggin and Chordin also regulate appropriate synovial 
joint development [22, 23]. Relative BMP over-expression 
results in an epiphyseal cartilage phenotype and joint fusion, 
rather than in hyaline cartilage and normal joint develop-
ment. Synovial joint development is also critically depend-
ent upon wingless (wnt) 4, wnt9a, and wnt 16 signalling 
within the interzone [24]. Whilst wnt signalling is not a 
requirement for joint initiation, it is a requirement for proper 
development, including the formation of hyaline articular 
cartilage. Wnt4 and wnt9a knockout does not inhibit joint 
patterning but results in subsequent fusion [24, 25]. The 
molecular regulation of early joint patterning is not limited 
to the interzone. Indian hedgehog (IHH), expressed at the 
growth plate during long bone formation, also modulates 
developing joint architecture and Ihh knockout is also char-
acterised by joint fusion [26, 27].
Interzone formation is followed by a process of joint cavi-
tation that involves limited cell death [28], alterations in 
ibrillar collagen from type I to type II [17], and diferential 
growth of the joint elements as the clefts join to form the 
central synovial cavity, lined by the developing synovium 
and joint capsule [29]. The articular cartilage is formed by 
a layer of cells at the end of the epiphyseal growth plate 
[30]. Peripherally, the interzone mesenchyme gives rise to 
the ibrous joint capsule and supporting ligaments of the 
joint. Where the mesenchyme lines the capsule and articular 
surfaces, the mesenchymal cells form the synovial mem-
brane. These cells subsequently disappear from the articular 
cartilage surface, probably as a result of joint movement.
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The process of joint cavitation is thought to occur largely 
through mechanically induced changes in the extracellular 
matrix [30, 31]. Although interzone formation occurs in the 
absence of movement, skeletal muscle activity is required 
for both cavity formation and subsequent morphogenesis 
[14, 32–34]. During this period there is also an increase in 
expression of CD44 and increased hyaluronan synthesis that 
facilitates tissue separation and formation of a functional 
cavity [35], which is also thought to be under mechanical 
regulation [36]. Studies show that muscle imbalance during 
development results in abnormally shaped joints [37–39]. 
There is also evidence that some signalling mechanisms 
may be joint-speciic [20, 40]. An overview of the signalling 
networks involved in synovial joint development and their 
spatial colocation is shown in Fig. 2 (adapted from [12]). 
Joint growth and modelling continues beyond embryogen-
esis and throughout postnatal growth to skeletal maturity. 
This growth is regulated by a complex interplay of local 
molecular mechanisms that are, in turn, also regulated at 
the long-range level [41]. These processes are reviewed in 
detail elsewhere, [13, 42] but where perturbed, joint shape 
and surface congruity abnormalities may result that can give 
rise to secondary OA.
In the following sections, we consider several common 
complex conditions in which joint development is afected pre- 
or post-natally. The evidence base for these conditions comes 
from the epidemiological literature that uses its own lexicon 
of terms. For the purposes of this review, we use the term “risk 
factors” to mean variables that afect an individual’s chance 
of developing a disease. We use the term “susceptibility” to 
mean the individual’s overall chance of developing the disease. 
Note that the associations between individual risk factors and 
overall disease susceptibility may be causal (in which there is 
a direct mechanistic link), or represent a marker for the disease 
for which the mechanism of the link is unclear but the two are 
clearly associated (such as through a third factor). The terms 
variant and single nucleotide polymorphism (SNP) are used 
synonymously. We use the term “common variant” to describe 
risk alleles with a frequency of > 5% (or 0.05). Low-frequency 
variants have an allele frequency of between 1 and 5% (0.01 
to 0.05), and rare variants have a frequency of < 1% (or 0.01).
Fig. 1  Synovial joint development in the mouse. Longitudinal views 
depicting key steps in the formation of the knee joint. a The irst sign 
of a presumptive joint is a condensation of Col2 + limb bud progeni-
tors at the presumptive joint site; b Joint speciication is marked by 
induction of Gdf5 in the interzone and downregulation of Col2a1; c 
A joint space is formed by cavitation after progenitors for a variety 
of secondary joint structures are speciied from the Gdf5 + progeni-
tor pool; d Maturation of the synovial joint of the knee occurs during 
development and early postnatal life. Reproduced from Salazar et al. 
[165], with permission
 J. M. Wilkinson, E. Zeggini 
1 3
How Does Genetic Variation Inluence Joint 
Architecture?
As outlined above, it is clear that a complex interplay of 
molecular signalling and mechanical events are required for 
normal synovial joint development. Whilst loss of function 
mutations within genes critical to synovial joint morphogen-
esis lead to generalised musculoskeletal skeletal abnormali-
ties that may be incompatible with life, polymorphisms that 
arise in viable general populations also give rise to variations 
in joint shape that are heritable. The former group comprises 
a multitude of genetic mutations that provide critical insights 
into the functioning of individual genes required for normal 
musculoskeletal development. Here, we focus on common, 
complex disorders that arise within general populations 
and associate with the development of OA. These disorders 
may be broadly classiied into those that are captured within 
established disease deinitions, and those that represent sta-
tistical shape variation within populations.
The hip is the most common site for established patho-
logical variation in joint shape. Recognised disorders of 
hip joint morphology during growth include developmen-
tal dysplasia of the hip (DDH), Perthes’ disease, slipped 
capital femoral epiphysis (SCFE) and femoroacetabular 
impingement (FAI). These diseases describe discrete path-
ological entities that are associated with speciic clinical 
shape phenotypes.
Developmental Dysplasia of the Hip
DDH, the most common skeletal dysplasia, is characterised 
by abnormal development of the hip joint and presents with 
varying severity from mild uncovering of the femoral head 
to complete dislocation of the hip joint and acetabular apla-
sia (Fig. 3a) [43]. DDH has an incidence that ranges from 
0.06 per 1000 live births in individuals of African ances-
try to 76.1 per 1000 live births in Native Americans, and 
with an incidence in the UK European population of 3.6 per 
1000 [44]. The aetiology of DDH is complex, involving both 
environmental and genetic risk factors. Known associations 
include female sex, irst-born, breech presentation, and fam-
ily history [44].
Family studies have demonstrated that heritable factors 
contribute between 50 and 85% of the total DDH susceptibil-
ity [45–47]. Stevenson et al. [48], in a familial aggregation 
study of 1649 distinct individuals from Utah, USA, with a 
DDH case: control ratio of 1:10, found a recurrent risk of 12 
in irst-degree relatives of those with DDH versus controls. 
Fig. 2  Spatial expression patterns (a) and principal signaling path-
ways (b) in synovial joint development. The expression domains of 
critical signalling pathway components are regionally restricted dur-
ing development of synovial joints. AC articular cartilage, IZ inter-
zone, JC joint capsule. Reproduced from Salva et al. [12], with per-
mission
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Fig. 3  Disorders of the growing hip joint. a Bilateral hip dysplasia 
in a skeletally mature individual. The acetabuli are typically shallow 
and steep, and there is extrusion of the femoral heads with evidence 
of decreased lateral coverage (arrows); b Perthes’ disease of the right 
hip in a skeletally mature individual. The right femoral head is broad 
and lattened and the corresponding acetabululm is similarly shaped 
(arrow). c Slipped capital femoral epiphysis of the left hip in an ado-
lescent male. The epiphysis has slipped posteromedially from the 
physis (arrow); d Bilateral cam lesions in a skeletally maturing male, 
arrows show lateral head-neck junction prominence; e Bilateral pin-
cer lesions in a skeletally mature male, arrows show over-coverage of 
femoral head
 J. M. Wilkinson, E. Zeggini 
1 3
Li et al. [46], in a case–control familial study of Chinese 
individuals with DDH, reported a heritability of 84%, and 
a sibling recurrent risk of probands that was tenfold that 
of the siblings of controls. Heritability may also be esti-
mated at the population level amongst unrelated individu-
als using genome-wide association study (GWAS) analysis 
approaches. Hatzikotoulas et al. [49], using genetic complex 
trait analysis [50] across 770 DDH cases and 3,364 con-
trols in a discovery scan of 257,000 directly typed genetic 
variants with a minor allele frequency of > 0.01, found that 
common variants explained 55% of the liability-scale herit-
ability, and was equally distributed across chromosomes.
Genome-wide linkage analysis (GWLA) has identiied 
several chromosomal regions segregating within large DDH 
pedigrees. Feldman et al. [51], in a GWLA on an 18-member 
multigeneration family, the proband of which was severely 
afected by DDH, identiied a 4 Mb region on chromosome 
17q21. Candidate genes coded in this region are the HOXB 
cluster of homeobox genes, COL1A1 and DLX3. A Japanese 
GWLA of a 4-generation family containing eight patients 
with familial osteoarthritis of the hip associated with acetab-
ular dysplasia suggested linkage at 13q22 [52]. A GWLA of 
a large South African family of European origin with Beukes 
hip dysplasia, an autosomal dominant disorder of variable 
penetrance that is characterised by bilateral dysmorphism of 
the proximal femur, mapped the causal gene to a 3.34 Mb 
region at 4q35 [53]. Several candidate gene studies have 
also suggested associations between genetic variants and 
DDH, including GDF5, TBX4, ASPN, and IL6, although 
only GDF5 has been independently replicated and reached 
genome-wide statistical signiicance levels (Table 1).
Genome-wide association analysis enables a hypothesis-
free approach to interrogating the entire human genome for 
potential associations with a disease. In a GWAS of 770 
DDH cases and 3364 population-based controls, Hatziko-
toulas et al. [49] identiied eleven correlated variants at 
genome-wide signiicance (P < 5.0 × 10−8) residing within 
the 5ƍuntranslated region of GDF5 (20q11.22). Independ-
ent signals were replicated in three DDH cohorts of UK 
European ancestry, totalling 1129 cases and 4652 controls. 
Following meta-analysis, rs143384 in GDF5 (OR [95% CI] 
1.44 [1.34–1.56], P = 3.55 × 10−22) was robustly associated 
with DDH, reaching genome-wide signiicance in both the 
discovery and the replication cohorts. Gene-based associa-
tion analysis in this cohort also implicated variation within 
UQCC1, MMP24, and RETSAT at P < 5 × 10–8. UQCC1 lies 
adjacent to GDF5 and encodes a trans-membrane protein 
ubiquinol-cytochrome-c reductase complex chaperone. 
UQCC is expressed in diferentiating chondrocytes and 
regulates growth control [54, 55]. Variants in this gene are 
also associated with bone size [56], height [57] and hip axis 
length [58]. MMP24 encodes a member of the peptidase 
M10 family of matrix metalloproteinases that are involved in 
the breakdown of extracellular matrix in embryonic develop-
ment and tissue remodelling [59]. Sequence variants within 
MMP24 have also been associated with childhood height 
[60, 61]. RETSAT codes for retinol saturase, an enzyme cen-
trally involved in the metabolism of vitamin A [62]. Retinoic 
acid signalling is essential for normal limb bud development, 
including bone and cartilage formation [63].
Perthes’ Disease
The term Perthes’ disease describes idiopathic osteonecrosis 
of the femoral head in children. Depending upon the age of 
onset and the capacity of the developing hip to remodel, the 
disease results in femoral head and acetabular shape abnor-
malities of varying severity (Fig. 3b). Perthes’ disease varies 
greatly in incidence between geographic areas and ethnic 
groups, but in Western European populations the prevalence 
is typically between 5 and 15 per 100,000 children under 
the age of 15 years [64]. The condition is thought to have 
a multifactorial inheritance pattern, with a sibling and of-
spring recurrent risk of 2.6% in the UK, based upon the fam-
ily history of 412 index cases [65]. In a recent study using 
the Danish Twin Register, Metcalfe et al. examined 81 twin 
pairs [66] and identiied a familial clustering but no genetic 
component, with an overall proband concordance of 0.09. 
Although several small case control association studies of 
the disease have been conducted, including a meta-analysis 
of hypercoagulability genetic polymorphisms totalling 824 
cases and 2033 controls [67], only variation within Factor V 
Leiden thrombophilia (an inherited disorder of blood clot-
ting) was identiied as a possible risk locus (pooled OR 3.10 
[95%CI 1.68–5.72]) [67]. Thus, although geographic and 
familial clustering is clear in Perthes’ disease, the genetic 
component appears to be small. However, this may be due to 
the limited sample size and hence power of studies to date.
Slipped Capital Femoral Epiphysis
Slipped capital femoral epiphysis (SCFE) is a disorder of 
the hip that is characterised by displacement of the capital 
femoral epiphysis from the metaphysis through the physis, 
and results in a characteristic shape abnormality of the hip 
joint (Fig. 3c). It is a disorder of the adolescent developing 
hip, is more common in males, and has an incidence that 
is similar to that of Perthes’ disease [68]. The condition is 
thought to have an endocrine aetiology and can cluster in 
families [69, 70], but to date, powered studies to determine 
any heritable component have not been conducted.
Femoroacetabular Impingement
The term FAI describes morphological abnormalities of the 
femoral head–neck junction, acetabulum, or both, resulting 
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in abnormal contact between the proximal femur and the 
pelvic acetabulum at the hip joint [71]. Two basic patholo-
gies are described. In “Cam” morphology, a non-spherical 
extension of the femoral head–neck junction (usually ante-
rolateral) causes abutment into the adjacent acetabular cav-
ity [72] (Fig. 3d). In “Pincer” morphology, local or global 
over-coverage of the acetabulum results in linear impact 
of the acetabular rim against the head-neck junction [73] 
(Fig. 3e). The two deformities may also coexist in “Com-
bined” lesions. The FAI hip shape abnormality develops dur-
ing the adolescent phase of skeletal growth before closure of 
the growth plate and has been associated with higher levels 
of sporting activity [74], although a causal link to exercise 
remains unclear. Asymptomatic FAI is highly prevalent 
(estimated at up to 75%) in populations of European descent 
(with cam lesions being more common in males) but is rare 
in Asian populations [75–78].
The heritable basis of FAI as a distinct hip shape abnor-
mality has not yet been studied in depth. This is perhaps 
unsurprising, as its development can only be deinitively 
determined at closure of growth plate [79], and there are 
few clinical reasons to image the hip in asymptomatic young 
adults. However, small-scale analyses do exist. Pollard et al. 
compared 96 siblings (mean age 38 years) of 64 patients 
(mean age 36) treated for FAI with a spouse control group 
of 77 individuals (mean age 42) and found a relative risk 
of cam morphology of 2.8 (95%CI 1.8–4.2) and of pincer 
morphology of 2.0 (1.3–3.0). Pollard et al. also examined 
Table 1  Summary of the published genetic associations with DDH
GWLA genome-wide linkage analysis, CGAS candidate gene association study, GWAS genome-wide association study
Study reference Gene/loci Chromosomal 
location
Study design SNP variant Phenotype Study population(s)
Feldman et al. 
(2010) [51]
17q21.31–17q22 17q21.31–17q22 GWLA – DDH American and 
Chinese
Mabuchi et al. 
(2006) [52]
13q22 13q22 GWLA – DDH Japanese
Watson et al. 
(2015) [53]
UFSP 4q35 GWLA and exome 
sequencing
c.868T > C Beukes hip dys-
plasia
South African
Feldman et al. 
(2013) [153]
CX3CR1 3p22.2 GWLA and exome 
sequencing
rs3732378 DDH American
Basit et al. (2017) 
[154]
HSPG2 p. Ala1110Ser GWLA and exome 
sequencing
c.3328G > T DDH Saudi Arabian
Basit et al. (2017) 
[154]
ATP2B4 p. Arg755Gln GWLA and exome 
sequencing
c.2264G > A DDH Saudi Arabian
Dai et al. (2008) 
[155], and 
Hatzikotoulas 
et al. (2018) [49]
GDF5 20q11.22 CGAS
GWAS and subse-
quent replication
rs143383, 
rs143384
CDH
DDH
Chinese females
United Kingdom
Wang et al. (2010) 
[156]
TBX4 17q23.2 CGAS rs374448 DDH Chinese
Shi et al. (2011) 
[157]
ASPN 9q22.31 CGAS D-repeat polymor-
phism of ASPN
DDH Chinese
Cengic et al. 
(2015) [158]
IL6 7p15.3 CGAS rs1800796 DDH Croatian
Cengic et al. 
(2015) [158]
TGFB1 19q13.2 CGAS rs1800470 DDH Croatian
Jia et al. (2012) 
[159]
PAPPA2 20q11.22 CGAS rs726252 DDH Chinese
Hao et al. (2014) 
[160]
HOXB9 17q21.32 CGAS rs2303486 DDH Chinese
Tian et al. (2012) 
[161]
HOXD9 2q31.1 CGAS rs711819 DDH Chinese females
Liu et al. (2014) 
[162]
DKK1 10q21.1 CGAS rs1569198 DDH Chinese
Zhao et al. (2013) 
[163]
COL1A1 17q21.33 CGAS rs113647555 DDH Chinese females
Sun et al. (2015) 
[164]
UQCC 20q11.22 GWAS rs6060373 DDH Chinese
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familial associations in ‘sibkids’ [80], a cohort with a heredi-
tary predisposition to hip osteoarthritis, and estimated an 
odds ratio for cam morphology of 2.1 (1.3–3.5) versus 
spouse controls but no diferences in pincer morphology 
or dysplasia. However, subjects were examined in mid-life 
when degenerative change is prevalent and a possible com-
mon environment underpinning of the associations were not 
examined. To date, no well-powered genome-wide or can-
didate variant analyses have been published that examine 
the relationship between speciic genetic risk factors and 
conventional radiographic indices of FAI.
Population Level Variation in Joint Shape
At the population level, computer vision methods have been 
applied to examine joint shape variation, although these 
phenotypes do not directly map to the clinical diagnoses 
of FAI or DDH. Statistical shape analysis describes the 
shape of a deformable object by applying principal compo-
nent analysis to a set of landmark points, and assumes each 
shape is a deformed version of a reference shape. Statistical 
shape models (SSM) may be applied to both 2-dimensional 
(2-D) and 3-D medical images [81]. SSMs have been used 
to describe the principal sources of population variation in 
shape at both the hip and the knee [82–85], and to describe 
those associated with trochlear dysplasia [86] and acute 
anterior cruciate ligament injury [87]. In the setting of FAI, 
SSMs have also been used to compare cam lesion deviation 
from the population reference femoral head-neck shape in 
pre-operative planning for surgical intervention [88].
The epidemiology of bone geometry has been of inter-
est in the exploration of the association between hip shape 
and osteoporotic fracture risk. In meta-analyses of overlap-
ping patient cohorts, Baird et al. [89], and Hsu et al. [90] 
examined genome-wide genotyped datasets in patients with 
DXA scans of the hip to identify relationships with proximal 
femoral SSMs and conventional measures of hip geometry, 
respectively. Baird et al. used SSMs to examine shape-
genotype associations in ~ 16,000 individuals across ~ 7 
million SNPs, identifying eight independent genome-wide 
signiicant variants (Bonferroni-corrected P < 5 × 10–9) that 
were associated with three modes of joint shape variation 
[89]. Seven of the variants were located within 200 kb of 
genes involved in endochondral ossiication (SOX9, PTHrP, 
RUNX1, NKX3-2, FGFR4, DICER1, and HHIP), suggest-
ing possible association with bone formation and by exten-
sion, joint shape. Hsu et al. examined conventional DXA-
derived hip structural analysis in 18,719 men and women. 
Using linkage disequilibrium (LD) score regression [91], 
they found that nominally-associating variants explained 
12%, 13%, 18%, and 22% of the heritable variation in neck-
shaft angle, femoral neck length, neck section modulus, and 
narrowest neck width, respectively. Following replication 
in independent cohorts, independent variants near IRIX/
ADAMTS16, LRP5/PPP6R32/GAL, CCDC91, FGFR4, 
NSD1, and RAB24 met genome-wide signiicance.
In a GWAS of bone area as a proxy for bone size quan-
titated by DXA, Styrkarsdottir et al. identiied 12 loci that 
are associated with hip or vertebral size [92], examining 
33.4 million sequence variants in Icelandic subjects across 
28,954 hip scans and 29,059 lumbar spine scans. They iden-
tiied rs143384 (20q11.22) in the GDF5 5ƍUTR as a locus 
for total hip (β = 0.071, P = 2.2 × 10–22) and trochanteric area 
(β = 0.071, P = 1.1 × 10–18). This locus had previously been 
robustly associated with DDH in the GWAS by Hatzikotou-
las et al. [49]. They also identiied two other hip area loci, 
17q24.3 in an intergenic region near SOX9 (intertrochanteric 
area β = 0.072, P = 6.2 × 10–18) and 4q31.21 in the 5ƍUTR 
of HHIP (femoral neck area β = 0.054, P = 8.4 × 10–14), that 
had previously been associated with hip shape SSMs in the 
Baird GWAS meta-analysis [89].
Joint Shape is an Important Risk Factor 
for OA
Conventional Measures of Joint Shape and OA 
Susceptibility
It has long been recognised that pathological developmental 
abnormalities of the hip joint such as DDH, Perthes’ dis-
ease, and SCFE commonly result in osteoarthritis and hip 
replacement [49, 93–95]. For example, individuals with mild 
DDH are 10 times more likely to develop OA compared 
with DDH-free controls [96]. It has only been more recently 
appreciated that subtle variations in joint shape also predis-
pose to degenerative change. Such variations in joint shape 
are commonly measured on plain radiographs in clinical 
practice to describe joint geometry (see Fig. 4 for common 
indices and their deinitions). Observations by Murray [97], 
and later by Solomon [98] and Harris [99], estimate that 
over 90% of individuals with idiopathic hip OA exhibit sub-
tle variations in acetabular and proximal femoral shape that 
precede the degenerative process (Fig. 5). These deformities 
are highly prevalent in European populations and can result 
in a focal mechanical overload of articular cartilage, leading 
to subsequent OA [72, 73, 100]. Doherty et al. [101], in a 
study of plain anteroposterior radiographs of the hip in 965 
OA cases and 1111 controls without radiographic OA, found 
the presence of cam morphology in at least 1 hip in 18% of 
cases versus 4% of controls (OR 6.95; 95%CI 4.64–10.41). 
An abnormal femoral head-to-neck ratio was present in of 
24% in cases versus 4% in controls (OR 12.01; 8.05–18.15). 
As the femoral head-to-neck ratio decreased, the presence 
of hip OA also rose.
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Demonstration that the converse is also true was made 
by Kim in 1989, reporting a high incidence of hip joint 
congruity and low incidence of both DDH and of OA in 
the Korean population [102]. Dudda et al. [103], compared 
morphological features associated with FAI in females from 
a Chinese cohort (Beijing OA Study) versus white women 
from the United States participating in the Study of Osteo-
porotic Fractures. They found low lateral centre-edge angles 
Fig. 4  Acetabular and proximal femoral morphological parameters 
associated with OA risk. a HTE horizontal toit externe, SA Sharp’s 
angle, and AT acetabular tilt; b AIDWR acetabular index of depth to 
width ratio; c LCEA lateral centre-edge angle and AA alpha angle; d 
FHFNR femoral head to femoral neck ratio and FNLWR femoral neck 
length to width ratio; e MPFA modiied proximal femoral angle and 
FNSA femoral neck-shaft angle
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suggesting dysplasia (< 20°) more often in the Chinese (22% 
of hips versus 7% in whites, p = 0.005), whilst low mean 
impingement angles (83.6° versus 87.0°, p = 0.03) and lat-
eral centre-edge angles suggestive of impingement (23% ver-
sus 11%, p = 0.008) were more common in women of Euro-
pean descent. More recently, Edwards et al. examined hip 
plain radiographic morphological characteristics in individu-
als of European descent, African Americans and Chinese 
men and women with no radiographic hip OA [104]. They 
found that the Chinese group had more shallow and narrow 
acetabular sockets, reduced femoral head coverage, smaller 
femoral head diameter, and a lesser femoral neck-shaft angle 
versus the other ethnic groups. Taken together, these ind-
ings are consistent with the epidemiological observation that 
idiopathic OA is more prevalent in Europeans [105], whilst 
in Asian populations hip OA is more commonly associated 
with a DDH morphology.
Deformities associated with cam-type FAI and subtle 
DDH morphology are also independent predictors of inci-
dent radiographic OA and progression to hip replacement 
in longitudinal studies. Nicholls et al. [106], found that cam 
morphology, identiied by an alpha angle of greater than 65°, 
had an increased risk of radiographic OA and hip replace-
ment over 2 decades [107], with each degree increase in 
alpha angle conferring a 5% and 3% increase in risk respec-
tively. Agricola et al. found similar relationships between 
increasing alpha angle (> cam morphology) and OA pro-
gression in the CHECK cohort [108]. Thomas et al. [107], 
found that mild DDH increased the risk of radiographic OA 
development and hip replacement over 2 decades, with each 
degree reduction in lateral centre edge angle below 28° asso-
ciated with a 14% and 21% increase in risk of OA and hip 
replacement, respectively [107]. However, no clear associa-
tions have been identiied between isolated pincer-type FAI 
and future OA risk [106–109].
Statistical Models of Joint Shape and OA 
Susceptibility
SSMs capture information that is predictive of OA and that 
is not present in predeined radiographic geometric meas-
ures, and vice versa. When combined, they add to the predic-
tive value for incident OA above clinical risk factors. Waars-
ing et al. [110], examined DXA images of the hip in 218 men 
and women with established hip OA followed over 2 years. 
They demonstrated that various shape and texture modes 
correlated with clinical pain and function scores where plain 
radiographic measures (Kellgren-Lawrence (KL) score and 
minimum joint space width) did not. Castaño-Betancourt 
et al. [111], used SSMs and predeined geometry parameters 
derived from baseline plain hip radiographs to predict inci-
dent radiographic OA (KL score ≥ 2) over 6.5 years in 688 
individuals from the Rotterdam Study. They found that hip 
geometry alone was of similar predictive value to clinical 
risk factors of sex, age, and body mass index; and when com-
bined, added 7% to the prediction obtained by clinical risk 
factors alone (AUC = 0.67 (geometry), 0.66 (clinical), 0.73 
(geometry + clinical) [111]. Agricola et al. demonstrated in 
Fig. 5  The biomechanical consequences of non-normal hip shape. Illustration shows relationship between out of range hip shape parameters and 
the development of osteoarthritis
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female participants in the CHECK and Chingford cohorts 
that baseline (KL < 2) radiograph-derived hip SSMs were 
also associated with future THR [112].
SSMs are also emerging as a useful phenotyping tool 
to improve our understanding of the relationship between 
genotype and joint shape. In the irst of such studies, Baker-
LePain et al. [113], examined the association of candidate 
variants within the wnt antagonist FRZB with radiograph-
derived hip shape SSMs in a nested subsample (European-
ancestry women ≥ 65 years; 451 hip OA cases, 601 controls) 
from the Study of Osteoporotic Fractures. They found no 
association between genotype and case–control status or 
with acetabular depth or centre edge angle, but a weak 
association with mode 2 (amongst 10 modes) in subjects 
having at least 1 copy of the rs288326 or the rs7775 FRZB 
minor allele (P = 0.019 for each test). A subsequent analysis 
stratiied by presence of the rs288326 minor allele showed 
a weak positive association between the upper quartile of 
subjects for mode 2 with OA in those carrying the vari-
ant allele (P = 0.02), which led them to propose that genetic 
variation within FRZB may modulate the efect of hip shape 
on OA risk.
Subsequently, Lindner et  al. examined 41 candidate 
genetic variants (that had previously been associated with 
OA or hip morphology) and plain anteroposterior radio-
graphs of the non-OA-afected hip in 929 patients from the 
arcOGEN cohort [114, 115]. In univariate analysis they 
identiied an association between rs4836732 (within ASTN2) 
and mode 5 of the female SSM (p = 0.0016), and between 
rs6976 (within GLT8D1) and mode 7 of the mixed sex SSM 
(p = 0.0003). The multivariate analysis identiied associa-
tion between rs5009270 (near IFRD1) and a combination 
of modes 3, 4, and 9 of the mixed-sex SSM (p = 0.0004). In 
the Baird et al. hip shape GWAS [89], 3 of the genome-wide 
signiicant variants that were associated with shape mode 
variation are also established loci for hip OA, rs4836732 
(intronic variant within ASTN2), rs10743612 (intergenic 
variant downstream of PTHLH), and rs73197346 (intergenic 
variant upstream of RUNX1).
Fewer studies have examined the relationship between 
SSMs and knee OA. Haverkamp et al. examined diferences 
in knee shape by SSMs between women with prevalent knee 
OA versus those without OA in Rotterdam Study partici-
pants [116]. They found that the women with knee OA had 
SSMs that described a broader femur and tibia and also an 
elevated lateral tibial plateau, indings that are consistent 
with plain radiographic features in the presence of knee OA. 
Wise et al. [117], in a study of 304 knees with (KL ≥ 2) 
versus 304 knees without (KL < 2) incident OA from the 
Osteoarthritis Initiative found that SSMs of distal femoral 
and proximal tibial shape derived from plain anteroposterior 
knee radiographs only weakly and inconsistently modulated 
the relationship between sex and incident knee OA.
Bone Shape Remodelling in Response to OA
Care is required when interpreting the results of joint shape 
and OA susceptibility association analyses, as joint shape 
changes with OA severity. Gregory et al. [118] used SSMs 
of the proximal femur derived from plain radiographs of the 
hip at baseline and again after 6 years in 110 participants 
in the Rotterdam Study to quantify the deforming efect of 
OA progression on the proximal femur, and irst proposed 
SSMs as an imaging biomarker of hip OA progression. Simi-
larly, Hunter et al. [119], conducted a nested case–control 
study of knee MRI data within the Osteoarthritis Initiative 
and showed that bone area increased and shape changed 
more over 24 months in OA cases versus controls (OR case/
control 1.28–1.71 for area, and 1.22–1.64 for shape per SD 
change in each variable, respectively).
Such observations make the disentangling of causation 
from association challenging, particularly where low-reso-
lution modalities such as DXA are used in isolation to deine 
the joint shape and absence of OA at baseline. Further, DXA 
images present a distorted image of the hip that is magniied 
in the x-axis, because of the fan-beam image acquisition 
[120]. These limitations are not conined to DXA data, but 
may impact all SSMs based on 2-D imaging. For example, 
as OA progresses at the hip, ixed external rotation of the 
hip occurs that may also give the impression of a change 
in bone area or femoral neck-shaft angle. Similarly, femo-
ral head osteophytes lead to high alpha angles seen in Cam 
morphology, and lateral acetabular osteophytes produce pin-
cer morphology. Cross-sectional imaging modalities do not 
sufer such artefacts to the same extent. Recently, Inamdar 
et al. [121] conducted a 36-month longitudinal MRI study of 
variation in proximal femur 3D morphological shape (3D-
SSM) and associations with cartilage health in 46 men and 
women with developing hip osteoarthritis. They showed that 
3D-SSM characterising increases in head and neck volume 
and decreasing femoral neck anteversion were weakly asso-
ciated with progression of symptoms and MRI-identiied 
cartilage lesions.
Bone remodelling features have also been used to deine 
diferent phenotypes within established OA into normotro-
phic, hypertrophic, or atrophic, depending upon the result-
ant bone shape [122]. These diferences in bone remodel-
ling responses may also have genetic correlates that further 
impact on the observed genetic relationships between joint 
shape and OA. Panoutsopoulou et al. [123], examined the 
efect of clinically relevant endophenotyping according to 
site of maximal joint space narrowing (maxJSN) and bone 
remodelling response in a stratiied GWAS of the arcOGEN 
dataset, comparing 2118 radiographically-deined hip OA 
cases and 6500 population-based controls. They found that 
variation within LRCH1 was associated with site of maximal 
joint space narrowing (OR 0.70; 0.61–0.80), whilst variation 
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adjacent to STT3B was associated with a hypertrophic pat-
tern of remodelling (OR 1.45; 1.24–1.69). Both associations 
were completely attenuated in the non-stratiied analyses. 
Further, STT3B was over-expressed in OA-afected versus 
intact human cartilage in an analysis of hypertrophic versus 
atrophic bone remodelling pattern.
Evidence from OA Susceptibility Studies
Our understanding of the genetic epidemiology of OA has 
increased substantially over the last few years with the num-
ber of genome-wide scans reported on increasingly large 
patient cohorts. To date, these eforts have resulted in almost 
100 robustly replicating genome-wide signiicant OA risk 
loci being identiied [124–129]. The vast majority of these 
risk loci represent common variants with a small to mod-
erate efect size, consistent with the complex and highly 
polygenic architecture of the disease (Fig. 6). However, 
large-scale GWAS datasets are not commonly accompanied 
by radiographic phenotype data upon which to examine rela-
tionships with joint shape.
Zengini et al. [124], in a GWAS of the UKBiobank meta-
analysed with other cohorts totalling 30,727 cases and 
297,191 controls examining 16.5 million variants identiied 
nine novel, robust OA variants. They also conducted a nested 
substudy of osteoarthritis-related plain radiographic pheno-
types in mixed cohorts of smaller size (where radiographic 
data were available). Of the nine identiied variants in the 
primary analysis, several were associated with the minimum 
joint space width phenotype, but only a nominal association 
between an intergenic variant rs116882138 and centre-edge 
angle (a feature of DDH, β = − 1.1388, P = 0.03), and no 
association with alpha angle (a feature of cam morphology), 
was found. Tachmazidou et al. [125], in the largest GWAS of 
OA published to date, including 77,052 cases and 378,169 
controls in a meta-analysis examining 17.5million variants, 
identiied 64 signals (52 novel) at MAF > 0.01 on top of 
34 previously established loci [124, 126, 128, 130–142]. 
Pathways analysis using MAGMA, PASCAL, and DEPICT 
Fig. 6  Efect size and risk allele 
frequency of published osteo-
arthritis genetic risk loci. Each 
circle represents a published 
osteoarthritis risk single-nucleo-
tide variant plotted with its odds 
ratio (OR; y axis) as a function 
of the risk allele frequency 
(x-axis). The diferent size and 
colour of each circle shows the 
sibling relative risk ratio (λs) 
and the percentage of variance 
explained on the liability scale 
respectively  (h2L; calculated 
assuming 13.5% prevalence 
of OA). Gene annotations are 
taken from the Ensembl genome 
browser (human assembly 
GRCh37). The majority are 
common variants with small 
(OR < 2.0) efect sizes, only 
those with OR > 2.0 are named 
here
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identiied 64 biological processes, 46 of which are involved 
in bone, cartilage, or chondrocyte morphogenesis. Although 
associations with other demographic characteristics and dis-
ease states were examined by linkage disequilibrium regres-
sion analysis using LDHub [91], speciic direct associations 
with joint shape were not explored.
What Consistent Signals Arise from Both 
Joint Shape and OA Studies?
Although many studies have examined the genetics of OA, 
relatively few have examined the genetics of diseases of 
joint shape or the relationships between shape, joint shape 
disorders and OA. Hatzikotoulas et al., used LD regression 
to estimate the genetic correlation between DDH and hip 
OA in the UK Biobank hip OA dataset, identifying a posi-
tive genetic correlation (rg = 0.58 (s.e. = 0.21), P = 0.0047), 
but did not distinguish between a causal relationship ver-
sus shared genetic causes. Baird et al. [143], examined the 
relationship between 11 genetic loci for hip OA and DXA-
derived hip shape in 3111 women participating in the Avon 
Longitudinal Study of Parents and Children. They identi-
ied associations with at least nominal signiicance between 
3 OA risk loci (KLHDC5/PHTLH rs10492367, DOT1L 
rs12982744, and COL11A1 rs4907986) and hip shape. Co-
localisation analysis indicated sharing of genetic signals 
for hip shape and hip OA for the KLHDC5/PTHLH and 
COL11A1 loci. However, the cohort was not screened for 
the presence of radiographic OA prior to inclusion in the 
analysis and thus hip shape variation resulting from OA, 
rather than predisposing to it, cannot be excluded.
Whilst many risk loci that lie adjacent or within genes 
that have a role in mesenchymal cell function have been 
associated with subtle statistical variations in joint shape or 
OA susceptibility, relatively few speciic genes have been 
consistently identiied across both the joint shape and the 
osteoarthritis phenotypes. Some of the key implicated genes 
are outlined below.
Growth Diferentiating Factor 5 (GDF5), a member of 
the TGFβ signalling family, is a key regulator of joint mor-
phogenesis. Mutations in GDF5 results in brachydactyly and 
symphalangism [144]. Variation within GDF5 has also been 
widely associated with DDH [49], and also with hip osteo-
arthritis across multiple populations [124, 130]. Pooled evi-
dence for association from two independent Japanese studies 
attained genome-wide signiicance with allelic OR [95%CIs] 
of 1.79 [1.53–2.09], p = 2 × 10–13 [130]. This GDF5 SNP 
was later associated with knee OA in individuals of Euro-
pean descent in a subsequent meta-analysis across a total 
of 6861 knee OA cases and 10,103 controls, with allelic 
OR [95%CIs] of 1.16 [1.10–1.22], p = 9.6 × 10–9 [145], 
and in hip and knee OA across 30,727 cases and 297,191 
controls [124]. Chen et al. [146] have shown that the GDF5 
locus contains many separate regulatory elements that con-
trol expression of the gene at diferent joint sites, and that 
these lanking regions are large. Capellini et al. of the same 
group have also recently described a novel enhancer region 
GROW1 in an extended downstream regulatory region of 
GDF5 [147]. Most recently, the same group has used chon-
drocyte chromatin datasets to propose a model linking evo-
lutionary genetic variations within the GDF5-UQCC1 risk 
locus (rs6060369) that perturb regulatory constraint during 
knee development with subsequent knee OA in adult mice, 
and suggest an ortholog in chondrocyte evolution of the 
modern human knee that afects bone shape [148].
SOX9 is a pivotal transcription factor during joint devel-
opment and in adulthood, committing mesenchymal progen-
itors to the chondrocyte lineage, activating cartilage-speciic 
genes and modulating chondrocyte survival. SOX9 dei-
ciency, generally due to spontaneous mutations at the 17q24 
locus, causes campomelic dysplasia that is characterised by 
multiple long bone abnormalities, including brachydactyly 
and dislocation of the hips [149]. Common variation within 
SOX9 is associated with both OA and joint shape variation 
[89, 92, 125]. SOX9 lies within a relatively gene-free region 
on chromosome 17, with large domains (1.9 Mb upstream 
and 0.5 Mb downstream) that facilitate interaction with cis-
acting elements causing SOX9-dependent diseases [150].
Parathyroid hormone-like hormone, encoded by PTHLH, 
regulates endochondral bone formation as a downstream sig-
nalling pathway to RUNX2, through its receptor’s inhibitory 
action on chondrocyte development and diferentiation and 
pro-osteoblastic activity [151]. Mutations in PTHLH cause 
brachydactyly and short stature [152], whilst common vari-
ation at the PTHLH locus is associated with hip shape and 
OA [128, 143].
Collagen type XI, encoded by COL11A1, is an impor-
tant component of the growing skeleton, but its presence 
in the adult is mainly conined to articular cartilage and the 
intervertebral disc. Loss of function mutations In COL11A1 
cause ibrochondrogenesis type 1, a disorder characterised 
by severe skeletal abnormality and is usually fatal in early 
life; and Stickler and Marshall syndromes, disorders char-
acterised by less severe bone and joint abnormalities that 
are non-fatal. Common variation in COL11A1 is associated 
with hip shape variation and has been suggestively associ-
ated with hip OA, although not at genome-wide signiicance 
[114, 143]. The molecular mechanisms of these proposed 
variants on COL11A1 expression remain to be clariied.
Astrotactin 2, encoded by ASTN2, is most strongly 
expressed in the brain and plays a role in neuronal migration. 
ASTN2 deletion causes autism and schizophrenia. Despite 
the apparent lack of relation to joint morphogenesis and 
OA, common variation in ASTN2 is robustly associated with 
both hip shape and OA [89, 115, 128]. Although a proposed 
 J. M. Wilkinson, E. Zeggini 
1 3
mechanism relating to pain sensing and OA symptomatology 
has been suggested, this does not readily explain the shape 
association.
Although variation in genes identiied in the studies out-
lined above, including COL11A1, DOT1L, IHH, RUNX1, 
RETSAT, and many others may also link joint develop-
ment with subsequent OA, they have not been speciically 
included here, as they are yet to be established with both 
phenotypes at genome-wide signiicance.
Conclusions
The study of increasingly large genome-wide meta-analyses 
together with multi-omics at scale, is starting to revolution-
ise our understanding of the heritable biology of osteoarthri-
tis. We have established that 60% and 40% of susceptibil-
ity to hip and knee OA, respectively, is heritable. Current 
international initiatives, such as the GO Consortium https 
://www.genet ics-osteo arthr itis.com/home/index .html will 
further expand the depth and breadth of our understanding 
of the contribution of common and low-frequency variants 
to disease heritability. Study of the heritable biology of joint 
shape, and how it relates to OA risk, thus far, is yet to beneit 
from the same advantages of scale and phenotype speciicity. 
Advances have been made in understanding the contribution 
of hip shape to OA risk, and shape variation can be meas-
ured with varying degrees of accuracy by several methods. 
However, for OA at other sites including the knee, clear 
shape phenotypes are less readily identiied. The inluence 
of other risk factors, such as sex, obesity and joint injury at 
the knee also make establishing relationships between joint 
shape and genotype more complex. Future abilities to link 
relevant imaging data to clinical and genomic datasets will 
narrow this gap.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Disease GBD, Injury I, Prevalence C (2016) Global, regional, 
and national incidence, prevalence, and years lived with dis-
ability for 310 diseases and injuries, 1990–2015: a systematic 
analysis for the Global Burden of Disease Study 2015. Lancet 
388:1545–1602
 2. Global Burden of Disease Study C (2015) Global, regional, and 
national incidence, prevalence, and years lived with disability 
for 301 acute and chronic diseases and injuries in 188 countries, 
1990–2013: a systematic analysis for the Global Burden of Dis-
ease Study 2013. Lancet 386:743–800
 3. Nuesch E, Dieppe P, Reichenbach S, Williams S, If S, Juni P 
(2011) All cause and disease speciic mortality in patients with 
knee or hip osteoarthritis: population based cohort study. BMJ 
342:d1165
 4. Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, 
Helmick CG (2007) Medical care expenditures and earnings 
losses among persons with arthritis and other rheumatic con-
ditions in 2003, and comparisons with 1997. Arthritis Rheum 
56:1397–1407
 5. Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH 
(2018) Medical expenditures and earnings losses among US 
adults with arthritis in 2013. Arthritis Care Res (Hoboken) 
70:869–876
 6. MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector 
TD (2000) The genetic contribution to radiographic hip osteoar-
thritis in women: results of a classic twin study. Arthritis Rheum 
43:2410–2416
 7. Manek NJ, Hart D, Spector TD, MacGregor AJ (2003) The asso-
ciation of body mass index and osteoarthritis of the knee joint: an 
examination of genetic and environmental inluences. Arthritis 
Rheum 48:1024–1029
 8. Magnusson K, Turkiewicz A, Englund M (2019) Nature vs nur-
ture in knee osteoarthritis - the importance of age, sex and body 
mass index. Osteoarthritis Cartilage 27:586–592
 9. Griin DR, Dickenson EJ, Wall PDH, Achana F, Donovan JL, 
Griin J, Hobson R, Hutchinson CE, Jepson M, Parsons NR, 
Petrou S, Realpe A, Smith J, Foster NE, Group FAS (2018) Hip 
arthroscopy versus best conservative care for the treatment of 
femoroacetabular impingement syndrome (UK FASHIoN): a 
multicentre randomised controlled trial. Lancet 391:2225–2235
 10. Palmer AJR, Ayyar Gupta V, Fernquest S, Rombach I, Dutton 
SJ, Mansour R, Wood S, Khanduja V, Pollard TCB, McCaskie 
AW, Barker KL, Andrade T, Carr AJ, Beard DJ, Glyn-Jones S, 
Group FS (2019) Arthroscopic hip surgery compared with physi-
otherapy and activity modiication for the treatment of sympto-
matic femoroacetabular impingement: multicentre randomised 
controlled trial. BMJ 364:l185
 11. Dwyer T, Whelan D, Shah PS, Ajrawat P, Hoit G, Chahal J 
(2020) Operative versus nonoperative treatment of femoroac-
etabular impingement syndrome: a meta-analysis of short-term 
outcomes. Arthroscopy 36:263–273
 12. Salva JE, Merrill AE (2017) Signaling networks in joint develop-
ment. Dev Dyn 246:262–274
 13. Chijimatsu R, Saito T (2019) Mechanisms of synovial joint and 
articular cartilage development. Cell Mol Life Sci 76:3939–3952
 14. Mitrovic DR (1977) Development of the metatarsophalangeal 
joint of the chick embryo: morphological, ultrastructural and 
histochemical studies. Am J Anat 150:333–347
 15. Jenner F, A IJ, Cleary M, Heijsman D, Narcisi R, van der Spek 
PJ, Kremer A, van Weeren R, Brama P, van Osch GJ (2014) Dif-
ferential gene expression of the intermediate and outer interzone 
layers of developing articular cartilage in murine embryos. Stem 
Cells Dev 23:1883–1898
 16. Holder N (1977) An experimental investigation into the early 
development of the chick elbow joint. J Embryol Exp Morphol 
39:115–127
 17. Craig FM, Bentley G, Archer CW (1987) The spatial and tempo-
ral pattern of collagens I and II and keratan sulphate in the devel-
oping chick metatarsophalangeal joint. Development 99:383–391
The Genetic Epidemiology of Joint Shape and the Development of Osteoarthritis 
1 3
 18. Hotten G, Neidhardt H, Jacobowsky B, Pohl J (1994) Cloning 
and expression of recombinant human growth/diferentiation fac-
tor 5. Biochem Biophys Res Commun 204:646–652
 19. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, 
Lee SJ (1994) Limb alterations in brachypodism mice due to 
mutations in a new member of the TGF beta-superfamily. Nature 
368:639–643
 20. Storm EE, Kingsley DM (1996) Joint patterning defects caused 
by single and double mutations in members of the bone morpho-
genetic protein (BMP) family. Development 122:3969–3979
 21. Francis-West PH, Abdelfattah A, Chen P, Allen C, Parish J, Lad-
her R, Allen S, MacPherson S, Luyten FP, Archer CW (1999) 
Mechanisms of GDF-5 action during skeletal development. 
Development 126:1305–1315
 22. Brunet LJ, McMahon JA, McMahon AP, Harland RM (1998) 
Noggin, cartilage morphogenesis, and joint formation in the 
mammalian skeleton. Science 280:1455–1457
 23. Francis-West PH, Parish J, Lee K, Archer CW (1999) BMP/GDF-
signalling interactions during synovial joint development. Cell 
Tissue Res 296:111–119
 24. Spater D, Hill TP, Gruber M, Hartmann C (2006) Role of canoni-
cal Wnt-signalling in joint formation. Eur Cell Mater 12:71–80
 25. Spater D, Hill TP, O’Sullivan RJ, Gruber M, Conner DA, Hart-
mann C (2006) Wnt9a signaling is required for joint integrity 
and regulation of Ihh during chondrogenesis. Development 
133:3039–3049
 26. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, 
Tabin CJ (1996) Regulation of rate of cartilage diferentiation by 
Indian hedgehog and PTH-related protein. Science 273:613–622
 27. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, 
Karperien M, Deize LH, Ho C, Mulligan RC, Abou-Samra 
AB, Juppner H, Segre GV, Kronenberg HM (1996) PTH/PTHrP 
receptor in early development and Indian hedgehog-regulated 
bone growth. Science 273:663–666
 28. Ballard KJ, Holt SJ (1968) Cytological and cytochemical stud-
ies on cell death and digestion in the foetal rat foot: the role of 
macrophages and hydrolytic enzymes. J Cell Sci 3:245–262
 29. Mankin HJ (1964) Mitosis in articular cartilage of immature 
rabbits. A histologic, stathmokinetic (colchicine) and autoradio-
graphic study. Clin Orthop Relat Res 34:170–183
 30. Ito MM, Kida MY (2000) Morphological and biochemical re-
evaluation of the process of cavitation in the rat knee joint: cel-
lular and cell strata alterations in the interzone. J Anat 197(Pt 
4):659–679
 31. Lamb KJ, Lewthwaite JC, Lin JP, Simon D, Kavanagh E, 
Wheeler-Jones CP, Pitsillides AA (2003) Diverse range of 
fixed positional deformities and bone growth restraint pro-
voked by laccid paralysis in embryonic chicks. Int J Exp Pathol 
84:191–199
 32. Murray PD, Drachman DB (1969) The role of movement in the 
development of joints and related structures: the head and neck 
in the chick embryo. J Embryol Exp Morphol 22:349–371
 33. Mitrovic D (1982) Development of the articular cavity in para-
lyzed chick embryos and in chick embryo limb buds cultured on 
chorioallantoic membranes. Acta Anat (Basel) 113:313–324
 34. Osborne AC, Lamb KJ, Lewthwaite JC, Dowthwaite GP, Pitsil-
lides AA (2002) Short-term rigid and laccid paralyses diminish 
growth of embryonic chick limbs and abrogate joint cavity for-
mation but diferentially preserve pre-cavitated joints. J Muscu-
loskelet Neuronal Interact 2:448–456
 35. Dowthwaite GP, Edwards JC, Pitsillides AA (1998) An essential 
role for the interaction between hyaluronan and hyaluronan bind-
ing proteins during joint development. J Histochem Cytochem 
46:641–651
 36. Archer CW, Dowthwaite GP, Francis-West P (2003) Develop-
ment of synovial joints. Birth Defects Res C 69:144–155
 37. Giorgi M, Carriero A, Shefelbine SJ, Nowlan NC (2015) Efects 
of normal and abnormal loading conditions on morphogenesis 
of the prenatal hip joint: application to hip dysplasia. J Biomech 
48:3390–3397
 38. Ford CA, Nowlan NC, Thomopoulos S, Killian ML (2017) 
Efects of imbalanced muscle loading on hip joint development 
and maturation. J Orthop Res 35:1128–1136
 39. Brunt LH, Skinner RE, Roddy KA, Araujo NM, Rayield EJ, 
Hammond CL (2016) Diferential efects of altered patterns of 
movement and strain on joint cell behaviour and skeletal mor-
phogenesis. Osteoarthritis Cartilage 24:1940–1950
 40. Seo HS, Serra R (2007) Deletion of Tgfbr2 in Prx1-cre express-
ing mesenchyme results in defects in development of the long 
bones and joints. Dev Biol 310:304–316
 41. Jain L (2018) Hormonal regulation of human development. Clin 
Perinatol 45:xiii–xv
 42. Decker RS (2017) Articular cartilage and joint development from 
embryogenesis to adulthood. Semin Cell Dev Biol 62:50–56
 43. Harcke HT (1999) Developmental dysplasia of the hip: a spec-
trum of abnormality. Pediatrics 103:152
 44. Loder RT, Skopelja EN (2011) The epidemiology and demo-
graphics of hip dysplasia. ISRN Orthop 2011:238607
 45. Bjerkreim I, van der Hagen CB (1974) Congenital dislocation 
of the hip joint in Norway. V. Evaluation of genetic and environ-
mental factors. Clin Genet 5:433–448
 46. Li L, Sun K, Zhang L, Zhao Q, Cheng X, Dang Y (2013) Herit-
ability and sibling recurrent risk of developmental dysplasia of 
the hip in Chinese population. Eur J Clin Investig 43:589–594
 47. Atasu M, Akkoyunlu U, Tokgozoglu N, Say B (1972) The herit-
ability of liability to congenital dislocation of the hip. Turk J 
Pediatr 14:23–26
 48. Stevenson DA, Mineau G, Kerber RA, Viskochil DH, Schaefer 
C, Roach JW (2009) Familial predisposition to developmental 
dysplasia of the hip. J Pediatr Orthop 29:463–466
 49. Hatzikotoulas K, Roposch A, Consortium DDHCC, Shah KM, 
Clark MJ, Bratherton S, Limbani V, Steinberg J, Zengini E, War-
same K, Ratnayake M, Tselepi M, Schwartzentruber J, Loughlin 
J, Eastwood DM, Zeggini E, Wilkinson JM (2018) Genome-wide 
association study of developmental dysplasia of the hip identiies 
an association with GDF5. Commun Biol 1:56
 50. Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: a 
tool for genome-wide complex trait analysis. Am J Hum Genet 
88:76–82
 51. Feldman G, Dalsey C, Fertala K, Azimi D, Fortina P, Devoto M, 
Paciici M, Parvizi J (2010) The Otto Aufranc Award: identiica-
tion of a 4 Mb region on chromosome 17q21 linked to develop-
mental dysplasia of the hip in one 18-member, multigeneration 
family. Clin Orthop Relat Res 468:337–344
 52. Mabuchi A, Nakamura S, Takatori Y, Ikegawa S (2006) Familial 
osteoarthritis of the hip joint associated with acetabular dysplasia 
maps to chromosome 13q. Am J Hum Genet 79:163–168
 53. Watson CM, Crinnion LA, Gleghorn L, Newman WG, Ramesar 
R, Beighton P, Wallis GA (2015) Identiication of a mutation in 
the ubiquitin-fold modiier 1-speciic peptidase 2 gene, UFSP2, 
in an extended South African family with Beukes hip dysplasia. 
S Afr Med J 105:558–563
 54. Imabayashi H, Mori T, Gojo S, Kiyono T, Sugiyama T, Irie R, 
Isogai T, Hata J, Toyama Y, Umezawa A (2003) Rediferentiation 
of dediferentiated chondrocytes and chondrogenesis of human 
bone marrow stromal cells via chondrosphere formation with 
expression proiling by large-scale cDNA analysis. Exp Cell Res 
288:35–50
 55. Vetter K, Wurst W (2001) Expression of a novel mouse gene 
’mbFZb’ in distinct regions of the developing nervous system 
and the adult brain. Mech Dev 100:123–125
 J. M. Wilkinson, E. Zeggini 
1 3
 56. Deng FY, Dong SS, Xu XH, Liu YJ, Liu YZ, Shen H, Tian Q, Li 
J, Deng HW (2013) Genome-wide association study identiied 
UQCC locus for spine bone size in humans. Bone 53:129–133
 57. Sanna S, Jackson AU, Nagaraja R, Willer CJ, Chen WM, Bon-
nycastle LL, Shen H, Timpson N, Lettre G, Usala G, Chines 
PS, Stringham HM, Scott LJ, Dei M, Lai S, Albai G, Crisponi 
L, Naitza S, Doheny KF, Pugh EW, Ben-Shlomo Y, Ebrahim S, 
Lawlor DA, Bergman RN, Watanabe RM, Uda M, Tuomilehto J, 
Coresh J, Hirschhorn JN, Shuldiner AR, Schlessinger D, Collins 
FS, Davey Smith G, Boerwinkle E, Cao A, Boehnke M, Abecasis 
GR, Mohlke KL (2008) Common variants in the GDF5-UQCC 
region are associated with variation in human height. Nat Genet 
40:198–203
 58. Soranzo N, Rivadeneira F, Chinappen-Horsley U, Malkina I, 
Richards JB, Hammond N, Stolk L, Nica A, Inouye M, Hof-
man A, Stephens J, Wheeler E, Arp P, Gwilliam R, Jhamai PM, 
Potter S, Chaney A, Ghori MJ, Ravindrarajah R, Ermakov S, 
Estrada K, Pols HA, Williams FM, McArdle WL, van Meurs JB, 
Loos RJ, Dermitzakis ET, Ahmadi KR, Hart DJ, Ouwehand WH, 
Wareham NJ, Barroso I, Sandhu MS, Strachan DP, Livshits G, 
Spector TD, Uitterlinden AG, Deloukas P (2009) Meta-analysis 
of genome-wide scans for human adult stature identiies novel 
Loci and associations with measures of skeletal frame size. PLoS 
Genet 5:e1000445
 59. Borkakoti N (1998) Matrix metalloproteases: variations on a 
theme. Prog Biophys Mol Biol 70:73–94
 60. Fontenele EG, Moraes ME, d’Alva CB, Pinheiro DP, Landim 
SA, Barros FA, Trarbach EB, Mendonca BB, Jorge AA (2015) 
Association study of GWAS-derived loci with height in Brazilian 
children: importance of MAP3K3, MMP24 and IGF1R polymor-
phisms for height variation. Horm Res Paediatr 84:248–253
 61. Zhao J, Li M, Bradield JP, Zhang H, Mentch FD, Wang K, Slei-
man PM, Kim CE, Glessner JT, Hou C, Keating BJ, Thomas 
KA, Garris ML, Deliard S, Frackelton EC, Otieno FG, Chia-
vacci RM, Berkowitz RI, Hakonarson H, Grant SF (2010) The 
role of height-associated loci identiied in genome wide associa-
tion studies in the determination of pediatric stature. BMC Med 
Genet 11:96
 62. Moise AR, Kuksa V, Imanishi Y, Palczewski K (2004) Identiica-
tion of all-trans-retinol: all-trans-13,14-dihydroretinol saturase. 
J Biol Chem 279:50230–50242
 63. Ross SA, McCafery PJ, Drager UC, De Luca LM (2000) Reti-
noids in embryonal development. Physiol Rev 80:1021–1054
 64. Loder RT, Skopelja EN (2011) The epidemiology and demo-
graphics of legg-calve-perthes’ disease. ISRN Orthop 
2011:504393
 65. Hall DJ (1986) Genetic aspects of Perthes’ disease. A critical 
review. Clin Orthop Relat Res 209:100–114
 66. Metcalfe D, Van Dijck S, Parsons N, Christensen K, Perry DC 
(2016) A twin study of perthes disease. Pediatrics 137:e20153542
 67. Woratanarat P, Thaveeratitharm C, Woratanarat T, Angsanunt-
sukh C, Attia J, Thakkinstian A (2014) Meta-analysis of hyper-
coagulability genetic polymorphisms in Perthes disease. J Orthop 
Res 32:1–7
 68. Loder RT, Skopelja EN (2011) The epidemiology and demo-
graphics of slipped capital femoral epiphysis. ISRN Orthop 
2011:486512
 69. Rennie AM (1982) The inheritance of slipped upper femoral 
epiphysis. J Bone Jt Surg Br 64:180–184
 70. Witbreuk M, van Kemenade FJ, van der Sluijs JA, Jansma EP, 
Rotteveel J, van Royen BJ (2013) Slipped capital femoral epi-
physis and its association with endocrine, metabolic and chronic 
diseases: a systematic review of the literature. J Child Orthop 
7:213–223
 71. Ito K, Minka MA 2nd, Leunig M, Werlen S, Ganz R (2001) Fem-
oroacetabular impingement and the cam-efect. A MRI-based 
quantitative anatomical study of the femoral head-neck ofset. J 
Bone Jt Surg Br 83:171–176
 72. Ganz R, Parvizi J, Beck M, Leunig M, Notzli H, Siebenrock KA 
(2003) Femoroacetabular impingement: a cause for osteoarthritis 
of the hip. Clin Orthop Relat Res 417:112–120
 73. Beck M, Kalhor M, Leunig M, Ganz R (2005) Hip morphol-
ogy inluences the pattern of damage to the acetabular cartilage: 
femoroacetabular impingement as a cause of early osteoarthritis 
of the hip. J Bone Jt Surg Br 87:1012–1018
 74. Agricola R, Bessems JH, Ginai AZ, Heijboer MP, van der Hei-
jden RA, Verhaar JA, Weinans H, Waarsing JH (2012) The devel-
opment of Cam-type deformity in adolescent and young male 
soccer players. Am J Sports Med 40:1099–1106
 75. van Klij P, Heerey J, Waarsing JH, Agricola R (2018) The 
prevalence of cam and pincer morphology and its association 
with development of hip osteoarthritis. J Orthop Sports Phys 
Ther 48:230–238
 76. Laborie LB, Lehmann TG, Engesaeter IO, Eastwood DM, 
Engesaeter LB, Rosendahl K (2011) Prevalence of radio-
graphic indings thought to be associated with femoroacetabu-
lar impingement in a population-based cohort of 2081 healthy 
young adults. Radiology 260:494–502
 77. Laborie LB, Lehmann TG, Engesaeter IO, Engesaeter LB, 
Rosendahl K (2013) Is a positive femoroacetabular impinge-
ment test a common inding in healthy young adults? Clin 
Orthop Relat Res 471:2267–2277
 78. Laborie LB, Lehmann TG, Engesaeter IO, Sera F, Engesaeter 
LB, Rosendahl K (2014) The alpha angle in cam-type femo-
roacetabular impingement: new reference intervals based on 
2038 healthy young adults. Bone Jt J 96-B:449–454
 79. van Klij P, Heijboer MP, Ginai AZ, Verhaar JAN, Waarsing JH, 
Agricola R (2019) Cam morphology in young male football 
players mostly develops before proximal femoral growth plate 
closure: a prospective study with 5-yearfollow-up. Br J Sports 
Med 53:532–538
 80. Pollard TC, Batra RN, Judge A, Watkins B, McNally EG, Gill 
HS, Thomas GE, Glyn-Jones S, Arden NK, Carr AJ (2013) The 
hereditary predisposition to hip osteoarthritis and its associa-
tion with abnormal joint morphology. Osteoarthritis Cartilage 
21:314–321
 81. Heimann T, Meinzer HP (2009) Statistical shape models for 
3D medical image segmentation: a review. Med Image Anal 
13:543–563
 82. Yokota F, Okada T, Takao M, Sugano N, Tada Y, Sato Y (2009) 
Automated segmentation of the femur and pelvis from 3D CT 
data of diseased hip using hierarchical statistical shape model 
of joint structure. Med Image Comput Comput Assist Interv 
12:811–818
 83. Lindner C, Thiagarajah S, Wilkinson JM, arc OC, Wallis GA, 
Cootes TF (2013) Development of a fully automatic shape 
model matching (FASMM) system to derive statistical shape 
models from radiographs: application to the accurate capture 
and global representation of proximal femur shape. Osteoar-
thritis Cartilage 21:1537–1544
 84. Lindner C, Thiagarajah S, Wilkinson JM, Wallis GA, Cootes 
TF, arc OC (2013) Accurate bone segmentation in 2D radio-
graphs using fully automatic shape model matching based on 
regression-voting. Med Image Comput Comput Assist Interv 
16:181–189
 85. Fitzpatrick CK, Baldwin MA, Laz PJ, FitzPatrick DP, Lerner AL, 
Rullkoetter PJ (2011) Development of a statistical shape model 
of the patellofemoral joint for investigating relationships between 
shape and function. J Biomech 44:2446–2452
 86. Van Haver A, Mahieu P, Claessens T, Li H, Pattyn C, Verdonk 
P, Audenaert EA (2014) A statistical shape model of trochlear 
dysplasia of the knee. Knee 21:518–523
The Genetic Epidemiology of Joint Shape and the Development of Osteoarthritis 
1 3
 87. Pedoia V, Lansdown DA, Zaid M, McCulloch CE, Souza R, 
Ma CB, Li X (2015) Three-dimensional MRI-based statistical 
shape model and application to a cohort of knees with acute ACL 
injury. Osteoarthritis Cartilage 23:1695–1703
 88. Khanduja V, Baelde N, Dobbelaere A, Van Houcke J, Li H, Pat-
tyn C, Audenaert EA (2016) Patient-speciic assessment of dys-
morphism of the femoral head-neck junction: a statistical shape 
model approach. Int J Med Robot 12:765–772
 89. Baird DA, Evans DS, Kamanu FK, Gregory JS, Saunders 
FR, Giuraniuc CV, Barr RJ, Aspden RM, Jenkins D, Kiel DP, 
Orwoll ES, Cummings SR, Lane NE, Mullin BH, Williams 
FM, Richards JB, Wilson SG, Spector TD, Faber BG, Lawlor 
DA, Grundberg E, Ohlsson C, Pettersson-Kymmer U, Capellini 
TD, Richard D, Beck TJ, Evans DM, Paternoster L, Karasik D, 
Tobias JH (2019) Identiication of novel loci associated with 
hip shape: a meta-analysis of genomewide association studies. 
J Bone Miner Res 34:241–251
 90. Hsu YH, Estrada K, Evangelou E, Ackert-Bicknell C, Akes-
son K, Beck T, Brown SJ, Capellini T, Carbone L, Cauley J, 
Cheung CL, Cummings SR, Czerwinski S, Demissie S, Econs 
M, Evans D, Farber C, Gautvik K, Harris T, Kammerer C, 
Kemp J, Koller DL, Kung A, Lawlor D, Lee M, Lorentzon M, 
McGuigan F, Medina-Gomez C, Mitchell B, Newman A, Niel-
son C, Ohlsson C, Peacock M, Reppe S, Richards JB, Robbins 
J, Sigurdsson G, Spector TD, Stefansson K, Streeten E, Styr-
karsdottir U, Tobias J, Trajanoska K, Uitterlinden A, Vanden-
put L, Wilson SG, Yerges-Armstrong L, Young M, Zillikens 
MC, Rivadeneira F, Kiel DP, Karasik D (2019) Meta-analysis 
of genomewide association studies reveals genetic variants for 
hip bone geometry. J Bone Miner Res 34:1284–1296
 91. Zheng J, Erzurumluoglu AM, Elsworth BL, Kemp JP, Howe 
L, Haycock PC, Hemani G, Tansey K, Laurin C, Early G, Life-
course Epidemiology Eczema C, Pourcain BS, Warrington 
NM, Finucane HK, Price AL, Bulik-Sullivan BK, Anttila V, 
Paternoster L, Gaunt TR, Evans DM, Neale BM (2017) LD 
Hub: a centralized database and web interface to perform LD 
score regression that maximizes the potential of summary level 
GWAS data for SNP heritability and genetic correlation analy-
sis. Bioinformatics 33:272–279
 92. Styrkarsdottir U, Stefansson OA, Gunnarsdottir K, Thorleifs-
son G, Lund SH, Stefansdottir L, Juliusson K, Agustsdottir 
AB, Zink F, Halldorsson GH, Ivarsdottir EV, Benonisdottir S, 
Jonsson H, Gylfason A, Norland K, Trajanoska K, Boer CG, 
Southam L, Leung JCS, Tang NLS, Kwok TCY, Lee JSW, 
Ho SC, Byrjalsen I, Center JR, Lee SH, Koh JM, Lohmander 
LS, Ho-Pham LT, Nguyen TV, Eisman JA, Woo J, Leung PC, 
Loughlin J, Zeggini E, Christiansen C, Rivadeneira F, van 
Meurs J, Uitterlinden AG, Mogensen B, Jonsson H, Ingvarsson 
T, Sigurdsson G, Benediktsson R, Sulem P, Jonsdottir I, Mas-
son G, Holm H, Norddahl GL, Thorsteinsdottir U, Gudbjarts-
son DF, Stefansson K (2019) GWAS of bone size yields twelve 
loci that also afect height, BMD, osteoarthritis or fractures. 
Nat Commun 10:2054
 93. Lehmann TG, Engesaeter IO, Laborie LB, Lie SA, Rosen-
dahl K, Engesaeter LB (2012) Total hip arthroplasty in young 
adults, with focus on Perthes’ disease and slipped capital femo-
ral epiphysis: follow-up of 540 subjects reported to the Nor-
wegian Arthroplasty Register during 1987–2007. Acta Orthop 
83:159–164
 94. Wiberg G (1939) Studies on dysplastic acetabula and congenital 
subluxation of the hip joint with special references to the com-
plication of osteoarthritis. Acta Chir Scand 83:1–135
 95. Cooperman DR, Wallensten R, Stulberg SD (1983) Acetabular 
dysplasia in the adult. Clin Orthop Relat Res 175:79–85
 96. McWilliams DF, Doherty SA, Jenkins WD, Maciewicz RA, Muir 
KR, Zhang W, Doherty M (2010) Mild acetabular dysplasia and 
risk of osteoarthritis of the hip: a case-control study. Ann Rheum 
Dis 69:1774–1778
 97. Murray RO (1965) The aetiology of primary osteoarthritis of the 
hip. Br J Radiol 38:810–824
 98. Solomon L (1976) Patterns of osteoarthritis of the hip. J Bone Jt 
Surg Br 58:176–183
 99. Harris WH (1986) Etiology of osteoarthritis of the hip. Clin 
Orthop Relat Res 213:20–33
 100. Ganz R, Leunig M, Leunig-Ganz K, Harris WH (2008) The 
etiology of osteoarthritis of the hip: an integrated mechanical 
concept. Clin Orthop Relat Res 466:264–272
 101. Doherty M, Courtney P, Doherty S, Jenkins W, Maciewicz RA, 
Muir K, Zhang W (2008) Nonspherical femoral head shape (pis-
tol grip deformity), neck shaft angle, and risk of hip osteoarthri-
tis: a case-control study. Arthritis Rheum 58:3172–3182
 102. Kim YH (1989) Relationship between the sphericity of femoral 
head-acetabulum and the low incidence of primary osteoarthritis 
of the hip joint in Koreans. Yonsei Med J 30:280–287
 103. Dudda M, Kim YJ, Zhang Y, Nevitt MC, Xu L, Niu J, Goggins J, 
Doherty M, Felson DT (2011) Morphologic diferences between 
the hips of Chinese women and white women: could they account 
for the ethnic diference in the prevalence of hip osteoarthritis? 
Arthritis Rheum 63:2992–2999
 104. Edwards K, Leyland KM, Sanchez-Santos MT, Arden CP, Spec-
tor TD, Nelson AE, Jordan JM, Nevitt M, Hunter DJ, Arden NK 
(2019) Diferences between race and sex in measures of hip mor-
phology: a population-based comparative study. Osteoarthritis 
Cartilage. https ://doi.org/10.1016/j.joca.2019.10.014
 105. Hoaglund FT (2013) Primary osteoarthritis of the hip: a genetic 
disease caused by European genetic variants. J Bone Jt Surg Am 
95:463–468
 106. Nicholls AS, Kiran A, Pollard TC, Hart DJ, Arden CP, Spector T, 
Gill HS, Murray DW, Carr AJ, Arden NK (2011) The association 
between hip morphology parameters and nineteen-year risk of 
end-stage osteoarthritis of the hip: a nested case-control study. 
Arthritis Rheum 63:3392–3400
 107. Thomas GE, Palmer AJ, Batra RN, Kiran A, Hart D, Spector T, 
Javaid MK, Judge A, Murray DW, Carr AJ, Arden NK, Glyn-
Jones S (2014) Subclinical deformities of the hip are signiicant 
predictors of radiographic osteoarthritis and joint replacement 
in women. A 20 year longitudinal cohort study. Osteoarthritis 
Cartilage 22:1504–1510
 108. Agricola R, Heijboer MP, Bierma-Zeinstra SM, Verhaar JA, 
Weinans H, Waarsing JH (2013) Cam impingement causes 
osteoarthritis of the hip: a nationwide prospective cohort study 
(CHECK). Ann Rheum Dis 72:918–923
 109. Agricola R, Heijboer MP, Roze RH, Reijman M, Bierma-Zeinstra 
SM, Verhaar JA, Weinans H, Waarsing JH (2013) Pincer deform-
ity does not lead to osteoarthritis of the hip whereas acetabular 
dysplasia does: acetabular coverage and development of osteo-
arthritis in a nationwide prospective cohort study (CHECK). 
Osteoarthritis Cartilage 21:1514–1521
 110. Waarsing JH, Rozendaal RM, Verhaar JA, Bierma-Zeinstra SM, 
Weinans H (2010) A statistical model of shape and density of 
the proximal femur in relation to radiological and clinical OA of 
the hip. Osteoarthritis Cartilage 18:787–794
 111. Castano-Betancourt MC, Van Meurs JB, Bierma-Zeinstra S, 
Rivadeneira F, Hofman A, Weinans H, Uitterlinden AG, Waars-
ing JH (2013) The contribution of hip geometry to the prediction 
of hip osteoarthritis. Osteoarthritis Cartilage 21:1530–1536
 112. Agricola R, Leyland KM, Bierma-Zeinstra SM, Thomas GE, 
Emans PJ, Spector TD, Weinans H, Waarsing JH, Arden NK 
(2015) Validation of statistical shape modelling to predict hip 
osteoarthritis in females: data from two prospective cohort stud-
ies (Cohort Hip and Cohort Knee and Chingford). Rheumatology 
(Oxford) 54:2033–2041
 J. M. Wilkinson, E. Zeggini 
1 3
 113. Baker-Lepain JC, Lynch JA, Parimi N, McCulloch CE, Nevitt 
MC, Corr M, Lane NE (2012) Variant alleles of the Wnt antago-
nist FRZB are determinants of hip shape and modify the rela-
tionship between hip shape and osteoarthritis. Arthritis Rheum 
64:1457–1465
 114. Panoutsopoulou K, Southam L, Elliott KS, Wrayner N, Zhai G, 
Beazley C, Thorleifsson G, Arden NK, Carr A, Chapman K, 
Deloukas P, Doherty M, McCaskie A, Ollier WE, Ralston SH, 
Spector TD, Valdes AM, Wallis GA, Wilkinson JM, Arden E, 
Battley K, Blackburn H, Blanco FJ, Bumpstead S, Cupples LA, 
Day-Williams AG, Dixon K, Doherty SA, Esko T, Evangelou 
E, Felson D, Gomez-Reino JJ, Gonzalez A, Gordon A, Gwil-
liam R, Halldorsson BV, Hauksson VB, Hofman A, Hunt SE, 
Ioannidis JP, Ingvarsson T, Jonsdottir I, Jonsson H, Keen R, 
Kerkhof HJ, Kloppenburg MG, Koller N, Lakenberg N, Lane 
NE, Lee AT, Metspalu A, Meulenbelt I, Nevitt MC, O’Neill F, 
Parimi N, Potter SC, Rego-Perez I, Riancho JA, Sherburn K, 
Slagboom PE, Stefansson K, Styrkarsdottir U, Sumillera M, 
Swift D, Thorsteinsdottir U, Tsezou A, Uitterlinden AG, van 
Meurs JB, Watkins B, Wheeler M, Mitchell S, Zhu Y, Zmuda 
JM, Zeggini E, Loughlin J (2011) Insights into the genetic 
architecture of osteoarthritis from stage 1 of the arcOGEN 
study. Ann Rheum Dis 70:864–867
 115. Lindner C, Thiagarajah S, Wilkinson JM, Panoutsopoulou K, 
Day-Williams AG, arc OC, Cootes TF, Wallis GA (2015) Inves-
tigation of association between hip osteoarthritis susceptibility 
loci and radiographic proximal femur shape. Arthritis Rheumatol 
67:2076–2084
 116. Haverkamp DJ, Schiphof D, Bierma-Zeinstra SM, Weinans H, 
Waarsing JH (2011) Variation in joint shape of osteoarthritic 
knees. Arthritis Rheum 63:3401–3407
 117. Wise BL, Niu J, Zhang Y, Liu F, Pang J, Lynch JA, Lane NE 
(2018) Bone shape mediates the relationship between sex and 
incident knee osteoarthritis. BMC Musculoskelet Disord 19:331
 118. Gregory JS, Waarsing JH, Day J, Pols HA, Reijman M, Wein-
ans H, Aspden RM (2007) Early identiication of radiographic 
osteoarthritis of the hip using an active shape model to quantify 
changes in bone morphometric features: can hip shape tell us 
anything about the progression of osteoarthritis? Arthritis Rheum 
56:3634–3643
 119. Hunter D, Nevitt M, Lynch J, Kraus VB, Katz JN, Collins JE, 
Bowes M, Guermazi A, Roemer FW, Losina E, Consortium 
FOB (2016) Longitudinal validation of periarticular bone area 
and 3D shape as biomarkers for knee OA progression? Data 
from the FNIH OA Biomarkers Consortium. Ann Rheum Dis 
75:1607–1614
 120. Blake GM, Wahner HW, Fogelman I (1999) Technical principals 
of X-ray absorptiometry. In: Blake GM, Wahner HW, Fogelman I 
(eds) The evaluation of osteoporosis: dual energy X-ray absorp-
tiometry and ultrasound in clinical practice. Martin Dunitz Ltd, 
London, pp 45–71
 121. Inamdar G, Pedoia V, Rossi-Devries J, Samaan MA, Link TM, 
Souza RB, Majumdar S (2019) MR study of longitudinal vari-
ations in proximal femur 3D morphological shape and associa-
tions with cartilage health in hip osteoarthritis. J Orthop Res 
37:161–170
 122. Bombelli R (1983) Osteoarthritis of the hip: classiication and 
pathogenesis. Springer-Verlag, Berlin
 123. Panoutsopoulou K, Thiagarajah S, Zengini E, Day-Williams AG, 
Ramos YF, Meessen JM, Huetink K, Nelissen RG, Southam 
L, Rayner NW, arc OC, Doherty M, Meulenbelt I, Zeggini E, 
Wilkinson JM (2016) Radiographic endophenotyping in hip 
osteoarthritis improves the precision of genetic association 
analysis. Ann Rheum Dis. https ://doi.org/10.1136/annrh eumdi 
s-2016-21037 3
 124. Zengini E, Hatzikotoulas K, Tachmazidou I, Steinberg J, Hartwig 
FP, Southam L, Hackinger S, Boer CG, Styrkarsdottir U, Gilly 
A, Suveges D, Killian B, Ingvarsson T, Jonsson H, Babis GC, 
McCaskie A, Uitterlinden AG, van Meurs JBJ, Thorsteinsdot-
tir U, Stefansson K, Davey Smith G, Wilkinson JM, Zeggini E 
(2018) Genome-wide analyses using UK Biobank data provide 
insights into the genetic architecture of osteoarthritis. Nat Genet. 
https ://doi.org/10.1038/s4158 8-018-0079-y
 125. Tachmazidou I, Hatzikotoulas K, Southam L, Esparza-Gordillo J, 
Haberland V, Zheng J, Johnson T, Koprulu M, Zengini E, Stein-
berg J, Wilkinson JM, Bhatnagar S, Hofman JD, Buchan N, 
Süveges D, Yerges-Armstrong L, Smith GD, Gaunt TR, Scott 
RA, McCarthy LC, Zeggini E, arc OC (2019) Identiication of 
new therapeutic targets for osteoarthritis through genome-wide 
analyses of UK Biobank data. Nat Genet. https ://doi.org/10.1038/
s4158 8-018-0327-1
 126. Styrkarsdottir U, Helgason H, Sigurdsson A, Norddahl GL, 
Agustsdottir AB, Reynard LN, Villalvilla A, Halldorsson GH, 
Jonasdottir A, Magnusdottir A, Oddson A, Sulem G, Zink F, 
Sveinbjornsson G, Helgason A, Johannsdottir HS, Helgadottir A, 
Stefansson H, Gretarsdottir S, Rafnar T, Almdahl IS, Braekhus 
A, Fladby T, Selbaek G, Hosseinpanah F, Azizi F, Koh JM, Tang 
NLS, Daneshpour MS, Mayordomo JI, Welt C, Braund PS, Sam-
ani NJ, Kiemeney LA, Lohmander LS, Christiansen C, Andreas-
sen OA, arc Oc, Magnusson O, Masson G, Kong A, Jonsdottir I, 
Gudbjartsson D, Sulem P, Jonsson H, Loughlin J, Ingvarsson T, 
Thorsteinsdottir U, Stefansson K (2017) Whole-genome sequenc-
ing identiies rare genotypes in COMP and CHADL associated 
with high risk of hip osteoarthritis. Nat Genet 49:801–805
 127. Styrkarsdottir U, Lund SH, Thorleifsson G, Zink F, Stefansson 
OA, Sigurdsson JK, Juliusson K, Bjarnadottir K, Sigurbjorns-
dottir S, Jonsson S, Norland K, Stefansdottir L, Sigurdsson A, 
Sveinbjornsson G, Oddsson A, Bjornsdottir G, Gudmundsson 
RL, Halldorsson GH, Rafnar T, Jonsdottir I, Steingrimsson E, 
Norddahl GL, Masson G, Sulem P, Jonsson H, Ingvarsson T, 
Gudbjartsson DF, Thorsteinsdottir U, Stefansson K (2018) Meta-
analysis of Icelandic and UK data sets identiies missense vari-
ants in SMO, IL11, COL11A1 and 13 more new loci associated 
with osteoarthritis. Nat Genet 50:1681–1687
 128. arcOGEN Consortium; arcOGEN Collaborators ZE, Panoutso-
poulou K, Southam L, Rayner NW, Day-Williams AG, Lopes 
MC, Boraska V, Esko T, Evangelou E, Hofman A, Houwing-
Duistermaat JJ, Ingvarsson T, Jonsdottir I, Jonnson H, Kerkhof 
HJ, Kloppenburg M, Bos SD, Mangino M, Metrustry S, Slag-
boom PE, Thorleifsson G, Raine EV, Ratnayake M, Ricketts M, 
Beazley C, Blackburn H, Bumpstead S, Elliott KS, Hunt SE, Pot-
ter SC, Shin SY, Yadav VK, Zhai G, Sherburn K, Dixon K, Arden 
E, Aslam N, Battley PK, Carluke I, Doherty S, Gordon A, Joseph 
J, Keen R, Koller NC, Mitchell S, O’Neill F, Paling E, Reed 
MR, Rivadeneira F, Swift D, Walker K, Watkins B, Wheeler M, 
Birrell F, Ioannidis JP, Meulenbelt I, Metspalu A, Rai A, Salter 
D, Stefansson K, Stykarsdottir U, Uitterlinden AG, van Meurs 
JB, Chapman K, Deloukas P, Ollier WE, Wallis GA, Arden N, 
Carr A, Doherty M, McCaskie A, Willkinson JM, Ralston SH, 
Valdes AM, Spector TD, Loughlin J (2012) Identiication of new 
susceptibility loci for osteoarthritis (arcOGEN): a genome-wide 
association study. Lancet 380:815–823
 129. Reynard LN, Barter MJ (2019) Osteoarthritis year in review 
2019: genetics, genomics and epigenetics. Osteoarthritis Carti-
lage. https ://doi.org/10.1016/j.joca.2019.11.010
 130. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S, 
Fujioka M, Sudo A, Uchida A, Yamamoto S, Ozaki K, Takigawa 
M, Tanaka T, Nakamura Y, Jiang Q, Ikegawa S (2007) A func-
tional polymorphism in the 5’ UTR of GDF5 is associated with 
susceptibility to osteoarthritis. Nat Genet 39:529–533
The Genetic Epidemiology of Joint Shape and the Development of Osteoarthritis 
1 3
 131. Miyamoto Y, Shi D, Nakajima M, Ozaki K, Sudo A, Kotani A, 
Uchida A, Tanaka T, Fukui N, Tsunoda T, Takahashi A, Naka-
mura Y, Jiang Q, Ikegawa S (2008) Common variants in DVWA 
on chromosome 3p24.3 are associated with susceptibility to knee 
osteoarthritis. Nat Genet 40:994–998
 132. Nakajima M, Takahashi A, Kou I, Rodriguez-Fontenla C, 
Gomez-Reino JJ, Furuichi T, Dai J, Sudo A, Uchida A, Fukui N, 
Kubo M, Kamatani N, Tsunoda T, Malizos KN, Tsezou A, Gon-
zalez A, Nakamura Y, Ikegawa S (2010) New sequence variants 
in HLA class II/III region associated with susceptibility to knee 
osteoarthritis identiied by genome-wide association study. PLoS 
ONE 5:e9723
 133. Kerkhof HJ, Lories RJ, Meulenbelt I, Jonsdottir I, Valdes AM, 
Arp P, Ingvarsson T, Jhamai M, Jonsson H, Stolk L, Thorleifsson 
G, Zhai G, Zhang F, Zhu Y, van der Breggen R, Carr A, Doherty 
M, Doherty S, Felson DT, Gonzalez A, Halldorsson BV, Hart 
DJ, Hauksson VB, Hofman A, Ioannidis JP, Kloppenburg M, 
Lane NE, Loughlin J, Luyten FP, Nevitt MC, Parimi N, Pols HA, 
Rivadeneira F, Slagboom EP, Styrkarsdottir U, Tsezou A, van de 
Putte T, Zmuda J, Spector TD, Stefansson K, Uitterlinden AG, 
van Meurs JB (2010) A genome-wide association study identi-
ies an osteoarthritis susceptibility locus on chromosome 7q22. 
Arthritis Rheum 62:499–510
 134. Evangelou E, Valdes AM, Kerkhof HJ, Styrkarsdottir U, Zhu Y, 
Meulenbelt I, Lories RJ, Karassa FB, Tylzanowski P, Bos SD, 
Akune T, Arden NK, Carr A, Chapman K, Cupples LA, Dai J, 
Deloukas P, Doherty M, Doherty S, Engstrom G, Gonzalez A, 
Halldorsson BV, Hammond CL, Hart DJ, Helgadottir H, Hofman 
A, Ikegawa S, Ingvarsson T, Jiang Q, Jonsson H, Kaprio J, Kawa-
guchi H, Kisand K, Kloppenburg M, Kujala UM, Lohmander LS, 
Loughlin J, Luyten FP, Mabuchi A, McCaskie A, Nakajima M, 
Nilsson PM, Nishida N, Ollier WE, Panoutsopoulou K, van de 
Putte T, Ralston SH, Rivadeneira F, Saarela J, Schulte-Merker S, 
Shi D, Slagboom PE, Sudo A, Tamm A, Thorleifsson G, Thor-
steinsdottir U, Tsezou A, Wallis GA, Wilkinson JM, Yoshimura 
N, Zeggini E, Zhai G, Zhang F, Jonsdottir I, Uitterlinden AG, 
Felson DT, van Meurs JB, Stefansson K, Ioannidis JP, Spector 
TD (2011) Meta-analysis of genome-wide association studies 
conirms a susceptibility locus for knee osteoarthritis on chromo-
some 7q22. Ann Rheum Dis 70:349–355
 135. Day-Williams AG, Southam L, Panoutsopoulou K, Rayner NW, 
Esko T, Estrada K, Helgadottir HT, Hofman A, Ingvarsson T, 
Jonsson H, Keis A, Kerkhof HJ, Thorleifsson G, Arden NK, Carr 
A, Chapman K, Deloukas P, Loughlin J, McCaskie A, Ollier WE, 
Ralston SH, Spector TD, Wallis GA, Wilkinson JM, Aslam N, 
Birell F, Carluke I, Joseph J, Rai A, Reed M, Walker K, Doherty 
SA, Jonsdottir I, Maciewicz RA, Muir KR, Metspalu A, Rivade-
neira F, Stefansson K, Styrkarsdottir U, Uitterlinden AG, van 
Meurs JB, Zhang W, Valdes AM, Doherty M, Zeggini E (2011) 
A variant in MCF2L is associated with osteoarthritis. Am J Hum 
Genet. https ://doi.org/10.1016/j.ajhg.2011.08.001
 136. Evangelou E, Valdes AM, Castano-Betancourt MC, Doherty M, 
Doherty S, Esko T, Ingvarsson T, Ioannidis JP, Kloppenburg 
M, Metspalu A, Ntzani EE, Panoutsopoulou K, Slagboom PE, 
Southam L, Spector TD, Styrkarsdottir U, Stefanson K, Uitter-
linden AG, Wheeler M, Zeggini E, Meulenbelt I, van Meurs JB, 
arcOgen consortium tT-OAc (2013) The DOT1L rs12982744 
polymorphism is associated with osteoarthritis of the hip with 
genome-wide statistical signiicance in males. Ann Rheum Dis 
72:1264–1265
 137. Styrkarsdottir U, Thorleifsson G, Helgadottir HT, Bomer N, 
Metrustry S, Bierma-Zeinstra S, Strijbosch AM, Evangelou E, 
Hart D, Beekman M, Jonasdottir A, Sigurdsson A, Eiriksson 
FF, Thorsteinsdottir M, Frigge ML, Kong A, Gudjonsson SA, 
Magnusson OT, Masson G, Consortium T-O, arc OC, Hofman 
A, Arden NK, Ingvarsson T, Lohmander S, Kloppenburg M, 
Rivadeneira F, Nelissen RG, Spector T, Uitterlinden A, Slag-
boom PE, Thorsteinsdottir U, Jonsdottir I, Valdes AM, Meu-
lenbelt I, van Meurs J, Jonsson H, Stefansson K (2014) Severe 
osteoarthritis of the hand associates with common variants 
within the ALDH1A2 gene and with rare variants at 1p31. Nat 
Genet 46:498–502
 138. Evangelou E, Kerkhof HJ, Styrkarsdottir U, Ntzani EE, Bos 
SD, Esko T, Evans DS, Metrustry S, Panoutsopoulou K, 
Ramos YF, Thorleifsson G, Tsilidis KK, arc OC, Arden N, 
Aslam N, Bellamy N, Birrell F, Blanco FJ, Carr A, Chapman 
K, Day-Williams AG, Deloukas P, Doherty M, Engstrom G, 
Helgadottir HT, Hofman A, Ingvarsson T, Jonsson H, Keis 
A, Keurentjes JC, Kloppenburg M, Lind PA, McCaskie A, 
Martin NG, Milani L, Montgomery GW, Nelissen RG, Nevitt 
MC, Nilsson PM, Ollier WE, Parimi N, Rai A, Ralston SH, 
Reed MR, Riancho JA, Rivadeneira F, Rodriguez-Fontenla C, 
Southam L, Thorsteinsdottir U, Tsezou A, Wallis GA, Wilkin-
son JM, Gonzalez A, Lane NE, Lohmander LS, Loughlin J, 
Metspalu A, Uitterlinden AG, Jonsdottir I, Stefansson K, Slag-
boom PE, Zeggini E, Meulenbelt I, Ioannidis JP, Spector TD, 
van Meurs JB, Valdes AM (2014) A meta-analysis of genome-
wide association studies identiies novel variants associated 
with osteoarthritis of the hip. Ann Rheum Dis 73:2130–2136
 139. Hackinger S, Trajanoska K, Styrkarsdottir U, Zengini E, Stein-
berg J, Ritchie GRS, Hatzikotoulas K, Gilly A, Evangelou E, 
Kemp JP, arcOgen Consortium GC, Evans D, Ingvarsson T, 
Jonsson H, Thorsteinsdottir U, Stefansson K, McCaskie AW, 
Brooks RA, Wilkinson JM, Rivadeneira F, Zeggini E (2017) 
Evaluation of shared genetic aetiology between osteoarthritis 
and bone mineral density identiies SMAD3 as a novel osteo-
arthritis risk locus. Hum Mol Genet 26:3850–3858
 140. Liu Y, Yau MS, Yerges-Armstrong LM, Duggan DJ, Renner JB, 
Hochberg MC, Mitchell BD, Jackson RD, Jordan JM (2017) 
Genetic determinants of radiographic knee osteoarthritis in 
African Americans. J Rheumatol 44:1652–1658
 141. den Hollander W, Boer CG, Hart DJ, Yau MS, Ramos YFM, 
Metrustry S, Broer L, Deelen J, Cupples LA, Rivadeneira F, 
Kloppenburg M, Peters M, Spector TD, Hofman A, Slagboom 
PE, Nelissen R, Uitterlinden AG, Felson DT, Valdes AM, 
Meulenbelt I, van Meurs JJB (2017) Genome-wide association 
and functional studies identify a role for matrix Gla protein in 
osteoarthritis of the hand. Ann Rheum Dis 76:2046–2053
 142. Casalone E, Tachmazidou I, Zengini E, Hatzikotoulas K, Hack-
inger S, Suveges D, Steinberg J, Rayner NW, arc OC, Wilkin-
son JM, Panoutsopoulou K, Zeggini E (2018) A novel variant 
in GLIS3 is associated with osteoarthritis. Ann Rheum Dis 
77:620–623
 143. Baird DA, Paternoster L, Gregory JS, Faber BG, Saunders FR, 
Giuraniuc CV, Barr RJ, Lawlor DA, Aspden RM, Tobias JH 
(2018) Investigation of the relationship between susceptibil-
ity loci for hip osteoarthritis and dual X-ray absorptiometry-
derived hip shape in a population-based cohort of perimeno-
pausal women. Arthritis Rheumatol 70:1984–1993
 144. Everman DB, Bartels CF, Yang Y, Yanamandra N, Goodman 
FR, Mendoza-Londono JR, Savarirayan R, White SM, Graham 
JM Jr, Gale RP, Svarch E, Newman WG, Kleckers AR, Fran-
comano CA, Govindaiah V, Singh L, Morrison S, Thomas JT, 
Warman ML (2002) The mutational spectrum of brachydactyly 
type C. Am J Med Genet 112:291–296
 145. Valdes AM, Evangelou E, Kerkhof HJ, Tamm A, Doherty 
SA, Kisand K, Tamm A, Kerna I, Uitterlinden A, Hofman A, 
Rivadeneira F, Cooper C, Dennison EM, Zhang W, Muir KR, 
Ioannidis JP, Wheeler M, Maciewicz RA, van Meurs JB, Arden 
NK, Spector TD, Doherty M (2011) The GDF5 rs143383 
polymorphism is associated with osteoarthritis of the knee 
 J. M. Wilkinson, E. Zeggini 
1 3
with genome-wide statistical signiicance. Ann Rheum Dis 
70:873–875
 146. Chen H, Capellini TD, Schoor M, Mortlock DP, Reddi AH, 
Kingsley DM (2016) Heads, shoulders, elbows, knees, and 
toes: modular Gdf5 enhancers control diferent joints in the 
vertebrate skeleton. PLoS Genet 12:e1006454
 147. Capellini TD, Chen H, Cao J, Doxey AC, Kiapour AM, Schoor 
M, Kingsley DM (2017) Ancient selection for derived alleles at 
a GDF5 enhancer inluencing human growth and osteoarthritis 
risk. Nat Genet. https ://doi.org/10.1038/ng.3911
 148. Richard D, Liu Z, Cao J, Kiapour AM, Willen J, Yarlagadda 
S, Jagoda E, Kolachalama VB, Sieker JT, Chang GH, Muth-
uirulan P, Young M, Masson A, Konrad J, Hosseinzadeh S, 
Maridas DE, Rosen V, Krawetz R, Roach N, Capellini TD 
(2020) Evolutionary selection and constraint on human knee 
chondrocyte regulation impacts osteoarthritis risk. Cell. https 
://doi.org/10.1016/j.cell.2020.02.057
 149. Corbani S, Chouery E, Eid B, Jalkh N, Ghoch JA, Megarbane A 
(2011) Mild campomelic dysplasia: report on a case and review. 
Mol Syndromol 1:163–168
 150. Lefebvre V, Dvir-Ginzberg M (2017) SOX9 and the many facets 
of its regulation in the chondrocyte lineage. Connect Tissue Res 
58:2–14
 151. Komori T (2019) Regulation of proliferation, diferentiation and 
functions of osteoblasts by Runx2. Int J Mol Sci 20:1694
 152. Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, 
Blom E, Gillerot Y, Weigel JF, Kruger G, Hiort O, Seemann P, 
Mundlos S (2010) Deletion and point mutations of PTHLH cause 
brachydactyly type E. Am J Hum Genet 86:434–439
 153. Feldman GJ, Parvizi J, Levenstien M, Scott K, Erickson JA, For-
tina P, Devoto M, Peters CL (2013) Developmental dysplasia of 
the hip: linkage mapping and whole exome sequencing identify 
a shared variant in CX3CR1 in all afected members of a large 
multigeneration family. J Bone Miner Res 28:2540–2549
 154. Basit S, Albalawi AM, Alharby E, Khoshhal KI (2017) Exome 
sequencing identiied rare variants in genes HSPG2 and ATP2B4 
in a family segregating developmental dysplasia of the hip. BMC 
Med Genet 18:34
 155. Dai J, Shi D, Zhu P, Qin J, Ni H, Xu Y, Yao C, Zhu L, Zhu H, 
Zhao B, Wei J, Liu B, Ikegawa S, Jiang Q, Ding Y (2008) Asso-
ciation of a single nucleotide polymorphism in growth diferenti-
ate factor 5 with congenital dysplasia of the hip: a case-control 
study. Arthritis Res Ther 10:R126
 156. Wang K, Shi D, Zhu P, Dai J, Zhu L, Zhu H, Lv Y, Zhao B, Jiang 
Q (2010) Association of a single nucleotide polymorphism in 
Tbx4 with developmental dysplasia of the hip: a case-control 
study. Osteoarthritis Cartilage 18:1592–1595
 157. Shi D, Dai J, Zhu P, Qin J, Zhu L, Zhu H, Zhao B, Qiu X, Xu Z, 
Chen D, Yi L, Ikegawa S, Jiang Q (2011) Association of the D 
repeat polymorphism in the ASPN gene with developmental dys-
plasia of the hip: a case-control study in Han Chinese. Arthritis 
Res Ther 13:R27
 158. Cengic T, Trkulja V, Pavelic SK, Ratkaj I, Markova-Car E, 
Mikolaucic M, Kolundzic R (2015) Association of TGFB1 
29C/T and IL6 -572G/C polymorphisms with developmental 
hip dysplasia: a case-control study in adults with severe osteoar-
thritis. Int Orthop 39:793–798
 159. Jia J, Li L, Zhao Q, Zhang L, Ru J, Liu X, Li Q, Shi L (2012) 
Association of a single nucleotide polymorphism in pregnancy-
associated plasma protein-A2 with developmental dysplasia of 
the hip: a case-control study. Osteoarthritis Cartilage 20:60–63
 160. Hao Z, Dai J, Shi D, Xu Z, Chen D, Zhao B, Teng H, Jiang 
Q (2014) Association of a single nucleotide polymorphism in 
HOXB9 with developmental dysplasia of the hip: a case-control 
study. J Orthop Res 32:179–182
 161. Tian W, Zhao L, Wang J, Suo P, Wang J, Cheng L, Cheng Z, Jia 
J, Kan S, Wang B, Ma X (2012) Association analysis between 
HOXD9 genes and the development of developmental dysplasia 
of the hip in Chinese female Han population. BMC Musculo-
skelet Disord 13:59
 162. Liu S, Tian W, Wang J, Cheng L, Jia J, Ma X (2014) Two single-
nucleotide polymorphisms in the DKK1 gene are associated with 
developmental dysplasia of the hip in the Chinese Han female 
population. Genet Test Mol Biomark 18:557–561
 163. Zhao L, Tian W, Pan H, Zhu X, Wang J, Cheng Z, Cheng L, Ma 
X, Wang B (2013) Variations of the COL1A1 gene promoter and 
the relation to developmental dysplasia of the hip. Genet Test 
Mol Biomark 17:840–843
 164. Sun Y, Wang C, Hao Z, Dai J, Chen D, Xu Z, Shi D, Mao P, Teng 
H, Gao X, Hu Z, Shen H, Jiang Q (2015) A common variant of 
ubiquinol-cytochrome c reductase complex is associated with 
DDH. PLoS ONE 10:e0120212
 165. Salazar VS, Gamer LW, Rosen V (2016) BMP signalling in 
skeletal development, disease and repair. Nat Rev Endocrinol 
12:203–221
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional ailiations.
